{"study_id": 187080, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of docosahexaenoic acid (DHA) in attenuating or preventing cancer cachexia by examining its anti-inflammatory properties and impact on muscle protein degradation.", "results_summary": "The study suggests that DHA, as part of omega-3 PUFAs, may help attenuate cancer cachexia due to its anti-inflammatory effects, though the abstract does not provide specific quantitative results. It highlights the potential role of DHA in mitigating inflammatory mediators like TNF-\u03b1 and myostatin.", "population_specificity": "Patients with cancer cachexia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:27.303020+00:00"}
{"study_id": 187075, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of C20-22 \u03c93 PUFA, particularly docosahexaenoic acid (DHA), in attenuating preexisting nonalcoholic fatty liver disease (NAFLD) in adults and children.", "results_summary": "Dietary supplementation with DHA alone or combined with EPA was found to be tolerated and effective at reducing liver fat in NAFLD patients, though results were mixed regarding its impact on more severe markers like hepatic injury, inflammation, and fibrosis.", "population_specificity": "Adults and children with preexisting NAFLD.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:27.590362+00:00"}
{"study_id": 187079, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine if 3.0 g/d of omega-3 fatty acids (including docosahexaenoic acid) combined with resistance training improved body composition and reduced inflammatory cytokines in older men compared to placebo and resistance training alone.", "results_summary": "The study found that resistance training alone significantly improved body composition, muscle strength, and functional ability, but omega-3 supplementation provided no additional benefits and did not affect inflammatory cytokines.", "population_specificity": "Older men aged 65 years and above.", "effective_dosage": "3.0 g/d of omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:27.775696+00:00"}
{"study_id": 187081, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers sought to determine how maternal obesity affects the response to n-3 supplementation during pregnancy, specifically examining associations between obesity and PUFA concentrations and whether systemic response to n-3 supplementation differs by BMI.", "results_summary": "The study found that maternal obesity may influence PUFA concentrations and the response to n-3 supplementation, suggesting that BMI could be a factor in the effectiveness of n-3 supplementation during pregnancy. However, specific outcomes or statistical significance were not detailed in the abstract.", "population_specificity": "Pregnant women (556 participants, 46% lean, 28% obese) from the Maternal-Fetal Medicine Units Network trial.", "effective_dosage": "2g/day of n-3 (DHA + EPA)", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:28.413974+00:00"}
{"study_id": 187077, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether perioperative fish oil supplementation (containing docosahexaenoic acid) increases bleeding risk or affects transfusion requirements in cardiac surgery patients.", "results_summary": "Fish oil supplementation did not increase perioperative bleeding and was associated with fewer blood transfusions. Higher omega-3 PUFA levels correlated with lower bleeding risk.", "population_specificity": "1516 patients (mean age 63) undergoing coronary artery bypass graft or valve surgery.", "effective_dosage": "8-10 g/day preoperatively (2-5 days), then 2 g/day postoperatively.", "study_duration": "2-5 days preoperatively and continued postoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:28.702082+00:00"}
{"study_id": 187076, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify and validate clusters of specialized pro-resolving mediators (SPMs) derived from docosahexaenoic acid (DHA) in human plasma and serum, focusing on their role in accelerating the resolution of acute inflammation.", "results_summary": "The study identified specific clusters of SPMs, including resolvin (Rv)E1, RvD1, and lipoxin (LX)B, in human plasma and serum using LC-MS/MS-based lipid mediator metabololipidomics, with inter-laboratory validation confirming the findings. These SPMs, derived from DHA, were associated with promoting the resolution of acute inflammation.", "population_specificity": "Human plasma and serum samples (specific demographic details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:29.620679+00:00"}
{"study_id": 187085, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the impact of maternal supplementation with brain-specific fatty acids (DHA and ArA) during pregnancy on newborn infants' brain volumes.", "results_summary": "Males born to mothers supplemented with BSFA had significantly larger total brain volumes, total gray matter, corpus callosum, and cortical volumes compared to the placebo group, suggesting enhanced brain development. The study indicates differential sex sensitivity to BSFA supplementation.", "population_specificity": "Pregnant women and their newborn infants.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:35.993739+00:00"}
{"study_id": 187087, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility and potential efficacy of omega-3 fatty acid supplementation in reducing skin cancer risk among lung transplant recipients.", "results_summary": "The study found that omega-3 supplementation significantly increased plasma EPA levels and showed a trend toward reducing new skin cancer cases (6 in the intervention group vs. 11 in the placebo group), though the results were not statistically significant. No serious intervention-related adverse events were reported.", "population_specificity": "Lung transplant recipients aged 18 and older.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:37.010652+00:00"}
{"study_id": 187082, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the role of docosahexaenoic acid (DHA) in cardiovascular diseases, including its cardioprotective effects and benefits in neuropsychiatric disorders.", "results_summary": "The study found that DHA, along with EPA, has potential benefits in reducing the incidence and progression of cardiovascular diseases and neuropsychiatric disorders, though recent large-scale studies did not show significant benefits on cardiovascular outcomes. Mechanisms include triglyceride reduction, anti-inflammatory effects, and modulation of cardiac ion channels.", "population_specificity": "Adults, with specific mention of benefits in early brain development during infancy and potential applications in dementia and depression.", "effective_dosage": "Around 1 g of omega-3 polyunsaturated fatty acids per day (via fish oil supplements) or one to two servings of oily fish per week.", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:37.144223+00:00"}
{"study_id": 187083, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining omega-3 fatty acids (including docosahexaenoic acid) with psychoeducation improved mild to moderate depression more effectively than psychoeducation alone in workers.", "results_summary": "Both the omega-3 and placebo groups showed significant improvement in depression symptoms after 12 weeks, but there was no significant difference between the two groups. The study concluded that omega-3 fatty acids did not outperform placebo in alleviating depression symptoms.", "population_specificity": "Workers with mild to moderate depression.", "effective_dosage": "500 mg docosahexaenoic acid and 1000 mg eicosapentaenoic acid (EPA) daily (15 \u00d7 300 mg capsules per day).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:37.646542+00:00"}
{"study_id": 187084, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether \u03a9-3LCPUFA (including Docosahexaenoic Acid) could slow muscle loss, reduce fat mass, and improve insulin resistance in boys with Duchenne Muscular Dystrophy.", "results_summary": "The study found that \u03a9-3LCPUFA supplementation delayed lean mass loss, reduced fat mass, and lowered insulin resistance in boys with DMD, though effects on hyperinsulinemia were not significant. The percentage of boys with insulin resistance was significantly lower in the \u03a9-3LCPUFA group at 6 months compared to placebo.", "population_specificity": "Boys with Duchenne Muscular Dystrophy (DMD)", "effective_dosage": "2.9 g/day of \u03a9-3LCPUFA", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:37.782105+00:00"}
{"study_id": 187086, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify maternal characteristics related to DHA capsule intake and determine if DHA dose was associated with low and very low birth weight after controlling for relevant maternal characteristics.", "results_summary": "The study found that DHA supplementation (600 mg/day) during the last half of pregnancy reduced early preterm birth and very low birth weight. Capsule intake increased with maternal age and education, and higher intake was associated with lower probabilities of adverse birth outcomes.", "population_specificity": "Pregnant mothers from the Kansas City metropolitan area (n=345), including participants from two randomized trials.", "effective_dosage": "600 mg DHA/day (3 capsules of 200 mg each).", "study_duration": "Administered during the last half of pregnancy.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:37.788343+00:00"}
{"study_id": 187089, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the potential effects of docosahexaenoic acid (DHA) as a nutritional supplement for treating nonalcoholic fatty liver disease (NAFLD) in children.", "results_summary": "The abstract does not provide specific findings on DHA's effects but highlights the need for further clinical studies to validate its benefits and define appropriate dosages and durations for pediatric NAFLD patients.", "population_specificity": "Overweight/obese children with NAFLD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:37.919655+00:00"}
{"study_id": 187088, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of omega-3 fatty acids, including Docosahexaenoic Acid, in preventing and treating cardiovascular diseases and related conditions.", "results_summary": "The study found that omega-3 fatty acids, including Docosahexaenoic Acid, play a beneficial role in reducing the incidence of cardiovascular diseases, stroke, atherosclerosis, and other conditions like obesity and type 2 diabetes. A balanced diet and omega-3 supplementation were highlighted as essential for prevention and treatment.", "population_specificity": "General population, with implications for individuals at risk of cardiovascular diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:39.073626+00:00"}
{"study_id": 187090, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study does not investigate Docosahexaenoic Acid; it focuses on lycopene and green tea supplementation and dietary advice in men with raised PSA levels.", "results_summary": "The study does not report findings on Docosahexaenoic Acid.", "population_specificity": "128 men with raised PSA levels (prostate cancer-free).", "effective_dosage": "Not mentioned", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:44.111284+00:00"}
{"study_id": 187094, "supplement_id": 1089, "safety_score": "95", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA dietary supplementation improves behavior and cognition in school-aged, drug-na\u00efve children with ADHD.", "results_summary": "The study found no significant benefit of DHA on ADHD symptoms but observed small positive effects on psychosocial functioning, emotional problems, and focused attention. No adverse events were reported.", "population_specificity": "School-aged (7-14 years), drug-na\u00efve children with ADHD.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:45.449721+00:00"}
{"study_id": 187093, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether 8-week supplementation with EPA and DHA improves peripheral muscle performance during concentric contractions of elbow flexors in humans.", "results_summary": "The study found that EPA and DHA supplementation improved work output during the fifth set of contractions and reduced the decline in range of motion after exercise, while also inhibiting the increase in cross-sectional area post-exercise compared to placebo.", "population_specificity": "Sixteen healthy men", "effective_dosage": "600 mg EPA and 260 mg DHA per day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:45.763055+00:00"}
{"study_id": 187097, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the system-wide effects of DHA + EPA treatment on the plasma proteome in patients with NAFLD compared to placebo.", "results_summary": "DHA + EPA treatment affected pathways related to blood coagulation, immune/inflammatory response, and cholesterol metabolism, with reductions in key cardiovascular risk proteins like prothrombin and apolipoprotein B-100.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "4 g DHA + EPA daily.", "study_duration": "15-18 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:46.157803+00:00"}
{"study_id": 187096, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the effect of DHA-enriched fish oil supplements and grilled fish meals on cognitive and behavioral functioning in primary school students.", "results_summary": "DHA levels significantly increased in both intervention groups, with marked improvements in the Trail Making Test and behavioral functioning as measured by the Vanderbilt Assessment Scales. The fish oil group showed greater cognitive improvements compared to the fish-meal group.", "population_specificity": "Primary school students aged 9-10 years in Muscat, Oman.", "effective_dosage": "Fish oil supplement or one serving (100 g) of grilled fish per day (Sunday through Friday).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:46.440465+00:00"}
{"study_id": 187091, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers sought to determine whether LCPUFA supplementation, including DHA, during infancy influences brain function, structure, and metabolism at age 9.", "results_summary": "The study compared different DHA dosages (0.32%, 0.64%, 0.96% of total fatty acids) in infant formula and assessed long-term brain outcomes via MRI at age 9, but specific results on DHA's effects are not detailed in the abstract.", "population_specificity": "Newborns followed until age 9 years.", "effective_dosage": "0.32%, 0.64%, or 0.96% of total fatty acids as DHA in formula.", "study_duration": "From birth to 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:47.430129+00:00"}
{"study_id": 187098, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare plasma concentrations of DHA and EPA following administration of emulsified versus non-emulsified cod liver oil formulations.", "results_summary": "The emulsified cod liver oil formulation resulted in significantly higher plasma concentrations of DHA+EPA, DHA, and EPA compared to the non-emulsified formulation, as measured by iAUC over 24 hours.", "population_specificity": "47 healthy adults", "effective_dosage": "Single doses of 10% cod liver oil plus 10% cod oil (specific amounts not detailed)", "study_duration": "Single-dose administration with 24-hour follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:47.765983+00:00"}
{"study_id": 187095, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of docosahexaenoic acid (DHA) in preventing coronary heart disease (CHD) and its potential benefits, including anti-inflammatory, vasodilating, and antihypertensive effects.", "results_summary": "The study found that DHA, along with EPA, has beneficial effects for CHD prevention, including anti-inflammatory and vasodilating properties, but noted inconsistent results in clinical trials due to factors like study duration, dosage variations, and patient selection. The American Heart Association recommends 1 g of EPA plus DHA daily for CHD patients.", "population_specificity": "Subjects with and without coronary heart disease (CHD).", "effective_dosage": "1 g of EPA plus DHA per day (for CHD patients).", "study_duration": "Not specified.", "interactions": "Interaction with drugs used in CHD therapy mentioned, but specifics not provided.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:49.548297+00:00"}
{"study_id": 187101, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of maternal DHA supplementation during pregnancy and postpartum on infant motor and mental development, anthropometry, and morbidity patterns in India.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or recently completed without reported outcomes.", "population_specificity": "Pregnant women aged 18-35 years in India, followed through their infants' first 12 months of life.", "effective_dosage": "400 mg/d algal-derived DHA", "study_duration": "From \u226420 weeks gestation through 6 months postpartum", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:54.298300+00:00"}
{"study_id": 187099, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the combined effect of a low-carbohydrate, high-protein diet and omega-3 supplementation (including docosahexaenoic acid) on glycemic control in patients with type 2 diabetes.", "results_summary": "The study found that combining a low-carbohydrate, high-protein diet with omega-3 supplementation led to greater reductions in HbA1c and fasting glucose compared to either intervention alone, with faster effects on fasting glucose observed at 4 weeks.", "population_specificity": "Newly diagnosed patients with type 2 diabetes (n=122).", "effective_dosage": "6 g fish oil/day (containing 3.65 g combined docosahexaenoic acid, eicosapentaenoic acid, and docosapentaenoic acid).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:54.541641+00:00"}
{"study_id": 187100, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to test the effects of omega-3 fatty acid supplementation, including docosahexaenoic acid (DHA), on omega-3 levels, depressive symptoms, and functional measures in patients with chronic heart failure (CHF) and major depressive disorder.", "results_summary": "Omega-3 supplementation significantly increased omega-3 levels in red blood cells and was associated with improved cognitive depressive symptoms and social functioning, though no overall depression differences were found between groups.", "population_specificity": "Patients with CHF and major depressive disorder (Hamilton Depression Scale score \u226518).", "effective_dosage": "400 mg EPA/200 mg DHA fish oil at 2 g daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:55.631521+00:00"}
{"study_id": 187102, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess Docosahexaenoic Acid (DHA) concentrations in breast milk across different maternal diet patterns (vegan, vegetarian, omnivore) and its association with supplement use and seafood consumption.", "results_summary": "DHA concentrations in breast milk were low across all diet groups, with over 80% of participants below 0.30% of total fatty acids. No significant differences in DHA levels were found between vegan, vegetarian, and omnivore diets, reflecting low seafood intake and supplement use.", "population_specificity": "74 lactating women in the United States (26 vegan, 22 vegetarian, 26 omnivore).", "effective_dosage": "Not specified", "study_duration": "Single time-point assessment (cross-sectional)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:56.052853+00:00"}
{"study_id": 187104, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cotreatment with docosahexaenoic acid (DHA) and anticancer agents alters oxidative stress parameters to enhance conventional cancer treatment efficacy.", "results_summary": "Most in vitro and animal studies showed that DHA cotreatment increased lipid peroxidation and cytotoxicity compared to anticancer treatment alone, but vitamin E abolished these positive effects in 11 of 12 studies. Human studies were limited but suggested potential benefits in specific cancer types.", "population_specificity": "Cancer patients, animal models, and malignant cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Vitamin E was noted to counteract the oxidative stress effects of DHA.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:56.426219+00:00"}
{"study_id": 187103, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to analyze the morphometric characteristics and concentrations of DHA and EPA in various omega-3 supplements marketed for retinal disease.", "results_summary": "The study found significant variations in size, volume, and concentration of omega-3, DHA, and EPA among 10 commercial supplements, with Brudymacula\u00ae and Brudyretina 1.5\u00a0g\u00ae containing the highest DHA levels and Nutrof omega\u00ae the lowest.", "population_specificity": "Nutritional supplements available in Spain for retinal disease.", "effective_dosage": "Not specified (concentrations per tablet: mean DHA 210.72\u00b193.3 mg, EPA 112.34\u00b1140.98 mg).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:56.538250+00:00"}
{"study_id": 187106, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of n-3PUFAs (including Docosahexaenoic Acid) on cardiometabolic biomarkers in people with type 2 diabetes and determine if dosage or duration influenced these effects.", "results_summary": "n-3PUFAs supplementation significantly reduced LDL, VLDL, triglycerides, HbA1c, TNF-\u03b1, and IL-6 levels, but did not affect other lipid markers, glycaemic indices, inflammatory parameters, or blood pressure. Neither dosage nor duration explained the variability in responses.", "population_specificity": "People with type 2 diabetes (2,674 participants across 45 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:59.099710+00:00"}
{"study_id": 187107, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a multi-ingredient supplement containing Docosahexaenoic Acid (DHA) could improve cognitive function in older adults.", "results_summary": "The study found no significant differences in overall cognitive function or composite cognitive domains between the intervention and placebo groups, except for a minor improvement in Stroop Color-Word Time performance in the intervention group. The supplement had only a limited beneficial impact on cognitive function.", "population_specificity": "Community-dwelling older adults (68-83 years) with normal cognitive function.", "effective_dosage": "1500mg DHA daily (as part of a 3000mg omega-3 PUFA blend).", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:03.437541+00:00"}
{"study_id": 187108, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of prenatal DHA-rich fish oil supplementation on maternal and fetal cytokine production.", "results_summary": "Prenatal DHA-rich fish oil supplementation had no significant effect on maternal cytokine profiles or umbilical cord blood cytokine concentrations, though maternal serum DHA was associated with IL1\u03b1 and IL10 levels.", "population_specificity": "Pregnant women at risk for perinatal depressive symptoms (12-20 weeks gestation at enrollment).", "effective_dosage": "900 mg DHA plus 180 mg EPA daily.", "study_duration": "Approximately 22-24 weeks (from 12-20 weeks gestation to 34-36 weeks gestation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:03.712019+00:00"}
{"study_id": 187109, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of highly concentrated and purified DHA supplementation on human sperm function, particularly in infertile patients.", "results_summary": "DHA supplementation significantly improved progressive sperm motility, especially in asthenozoospermic patients, with benefits observed at different doses (0.5, 1, and 2 g) over 1 and 3 months. A slight reduction in oxidative stress was also noted, but no other molecular semen parameters showed significant changes.", "population_specificity": "Sixty infertile male patients recruited from a private assisted reproduction center.", "effective_dosage": "0.5, 1, and 2 g daily doses.", "study_duration": "1 and 3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:04.608610+00:00"}
{"study_id": 187110, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of omega-3 LC-PUFAs, including docosahexaenoic acid, on liver-related and metabolic outcomes in patients with NAFLD.", "results_summary": "Supplementation with n-3 LC-PUFAs improved several metabolic risk factors, liver enzyme levels, liver fat content, and steatosis score, but did not affect histological measures in NASH patients.", "population_specificity": "Adult and pediatric patients with NAFLD, including those with NASH.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:04.673423+00:00"}
{"study_id": 187111, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 20, "quality_score": 70, "study_goal": "The researchers aimed to test the effect of DHA dietary supplementation on macular function in patients with Stargardt disease.", "results_summary": "The study found no significant effect of DHA supplementation on macular function, as measured by multifocal ERG and other secondary outcomes. Serum DHA levels rose during supplementation but returned to baseline during placebo periods, with no meaningful changes in retinal function.", "population_specificity": "11 subjects (2 males, 9 females) with Stargardt disease.", "effective_dosage": "2000 mg/day", "study_duration": "Three months per intervention (DHA or placebo) in a crossover design.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:04.749534+00:00"}
{"study_id": 187112, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of omega-3 fatty acid supplementation, specifically docosahexaenoic acid (DHA), on depression during pregnancy and postpartum depression (PPD) after childbirth.", "results_summary": "Long-term DHA supplementation reduced the risk of PPD in healthy women but showed no benefit for lactating women or when continued after childbirth. DHA-rich oil supplementation during pregnancy and postpartum did not improve depression symptoms.", "population_specificity": "Pregnant and postpartum women, including healthy women and lactating women.", "effective_dosage": "Not specified", "study_duration": "Long-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:05.530322+00:00"}
{"study_id": 187113, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of high-dose DHA and EPA supplementation on LDL cholesterol concentrations and particle size in individuals at risk of cardiovascular disease.", "results_summary": "DHA increased LDL-C concentrations and mean LDL particle size while reducing small LDL proportion compared to EPA. Both DHA and EPA similarly decreased proprotein convertase subtilisin/kexin type 9 concentrations, but DHA increased LDL apoB100 turnover more than EPA.", "population_specificity": "48 men and 106 women with abdominal obesity and subclinical inflammation.", "effective_dosage": "2.7 g/d of DHA or EPA, provided as three 1-g capsules daily.", "study_duration": "10-week treatment phases separated by 9-week washout periods.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:08.707102+00:00"}
{"study_id": 187114, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA supplementation in preterm infants could improve frontal lobe function, specifically attention and distractibility.", "results_summary": "The abstract does not provide results as the study is ongoing (\"Pre-results\").", "population_specificity": "Infants born <29 weeks' gestation.", "effective_dosage": "60 mg/kg/day of DHA.", "study_duration": "From within the first 3 days of enteral feeding until 36 weeks' postmenstrual age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:11.854966+00:00"}
{"study_id": 187115, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of docosahexaenoic acid (DHA) as a coadjutant or standalone therapy in managing ADHD symptoms.", "results_summary": "The study compiled evidence suggesting DHA may help manage ADHD symptoms, though its efficacy as a single therapy or adjunct remains under investigation. The review highlights the potential of omega-3 PUFAs in ADHD treatment but does not conclusively establish strong clinical outcomes.", "population_specificity": "School-age children with ADHD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:13.474414+00:00"}
{"study_id": 187116, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "To determine if EPA and DHA supplementation improves physical function, exercise, and reduces musculoskeletal symptoms in coronary artery disease (CAD) patients.", "results_summary": "The study found that high-dose EPA and DHA improved physical function, increased exercise duration, and reduced joint replacements in CAD patients, with trends toward reduced pain and stiffness.", "population_specificity": "291 subjects with stable coronary artery disease (mean age 63.3 years).", "effective_dosage": "1.86 g EPA and 1.5 g DHA daily (Lovaza).", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:13.479052+00:00"}
{"study_id": 187119, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if n-3 PUFA supplementation, including docosahexaenoic acid, could attenuate inflammatory response and oxidative stress induced by high-intensity exercise in type 2 diabetic patients.", "results_summary": "The study found that n-3 PUFA supplementation reduced triglyceride levels and TRAP levels after exercise but did not significantly affect inflammatory or oxidative stress markers.", "population_specificity": "Thirty type 2 diabetic patients without chronic complications.", "effective_dosage": "120 mg docosahexaenoic acid (combined with 180 mg eicosapentaenoic acid) per capsule.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:14.339335+00:00"}
{"study_id": 187117, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to test the effects of EPA+DHA therapy on circulating levels of proinflammatory cytokines (IL-6, IL-1\u03b2, TNF-\u03b1) in middle-to-late adulthood adults with chronic venous leg ulcers.", "results_summary": "EPA+DHA therapy significantly reduced levels of IL-6, IL-1\u03b2, and TNF-\u03b1 after 4 weeks, with even greater reductions after 8 weeks, compared to placebo. The treatment group showed statistically significant lower cytokine levels at both time points.", "population_specificity": "Adults in middle to late adulthood (mean age: 60.6 years) with chronic venous leg ulcers.", "effective_dosage": "2.5 g/day (combined EPA+DHA)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:14.782917+00:00"}
{"study_id": 187118, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to test whether DHA-rich fish oil supplementation could slow cognitive decline in cognitively healthy older adults over 18 months.", "results_summary": "The study found no cognitive benefits from DHA supplementation, with a small negative effect on psychomotor speed. Effects varied by sex and APOE-\u03b54 carrier status, and supplementation increased perceived cognitive mistakes and oxidative stress.", "population_specificity": "Cognitively healthy Australian community-dwelling adults aged 65-90 years.", "effective_dosage": "1720 mg DHA and 600 mg eicosapentaenoic acid daily.", "study_duration": "18 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:15.348262+00:00"}
{"study_id": 187120, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of omega-3 fatty acids, particularly docosahexaenoic acid (DHA), on muscle damage, function, and exercise performance.", "results_summary": "The study suggests omega-3 fatty acids, including DHA, may improve endurance performance, reduce muscle damage, and enhance recovery, though optimal dosage and timing remain unclear.", "population_specificity": "Human and animal studies (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:16.922778+00:00"}
{"study_id": 187105, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a protein-based supplement containing docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) could reduce muscle soreness, improve countermovement jump performance, and enhance psychological well-being in professional Rugby Union players during pre-season training.", "results_summary": "The study found likely moderate beneficial effects of the omega-3 supplement on reducing lower body muscle soreness, improving countermovement jump performance, and reducing fatigue compared to placebo. These effects were observed over the 5-week intervention period.", "population_specificity": "20 professional Rugby Union players", "effective_dosage": "1546 mg omega-3 PUFA (551 mg EPA and 551 mg DHA) twice daily", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:21.041642+00:00"}
{"study_id": 187121, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of omega-3 PUFA-enriched hen eggs, including DHA, on microvascular reactivity, blood pressure, and serum lipid profile in healthy individuals.", "results_summary": "The study found that consumption of omega-3 PUFA-enriched eggs significantly enhanced microvascular reactivity, reduced triglycerides, hsCRP, and blood pressure in healthy subjects, suggesting potential cardiovascular benefits.", "population_specificity": "Young healthy individuals (control group N = 16, OMEGA-3 group N = 20).", "effective_dosage": "84 mg DHA per egg, 3 eggs daily (total 252 mg DHA/day).", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:21.048494+00:00"}
{"study_id": 187122, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prenatal supplementation with docosahexaenoic acid (DHA) improves postnatal lung function in offspring through 60 months of age.", "results_summary": "The study found no significant differences in pulmonary function between children whose mothers received DHA supplementation and those who received a placebo. DHA did not affect average lung function or its developmental trajectory through 60 months.", "population_specificity": "Mexican preschoolers whose mothers participated in a clinical trial during pregnancy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "From week 18-22 of gestation through delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:22.004428+00:00"}
{"study_id": 187123, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the physical, biochemical, and biological properties of omega-3 fatty acids, particularly their mechanisms of action on arterial wall properties and arterial stiffness in atherosclerosis.", "results_summary": "Omega-3 fatty acids, including docosahexaenoic acid, exhibit beneficial effects on cardiovascular health by improving endothelial function, reducing arterial stiffness, and displaying anti-inflammatory, anti-thrombotic, and anti-arrhythmogenic actions. They may also prevent the progression of atherosclerosis.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:22.138415+00:00"}
{"study_id": 187124, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the relationship between blood levels of docosahexaenoic acid (DHA) and cardiovascular disease (CVD) risk, as well as its potential role as a biomarker for chronic diseases.", "results_summary": "The study found that blood levels of DHA, combined with eicosapentaenoic acid (EPA), are inversely related to total mortality and fatal CVD events, supporting previous research despite null results from recent large supplementation trials.", "population_specificity": "Not specified (general population inferred from abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:22.472166+00:00"}
{"study_id": 187125, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine associations between Docosahexaenoic Acid (DHA) and depression or self-esteem scores in adolescents with low Omega-3 Index (O3I \u2264 5%).", "results_summary": "The study found no evidence for associations of DHA with depression or self-esteem scores in the studied population. Only n-6 docosapentaenoic acid (ObA) showed a weak negative association with depression.", "population_specificity": "Adolescents attending lower general secondary education (LGSE) with an O3I \u2264 5%.", "effective_dosage": "Not specified", "study_duration": "Not specified (baseline cross-sectional data analyzed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:23.962227+00:00"}
{"study_id": 187126, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether long-term supplementation with docosahexaenoic acid (DHA), combined with eicosapentaenoic acid (EPA), could prevent late-life depression and influence mood symptom trajectories in older adults.", "results_summary": "The abstract does not provide specific results regarding the effects of docosahexaenoic acid, as it focuses on the study's methodology and aims rather than outcomes.", "population_specificity": "25,874 older adults, with a subset of ~1,000 participants for detailed examinations.", "effective_dosage": "1 g/day (combined eicosapentaenoic acid + docosahexaenoic acid).", "study_duration": "Mean of 5 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:24.716519+00:00"}
{"study_id": 187127, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize evidence on whether docosahexaenoic acid (DHA) and fish oil supplementation reduce adiposity by activating thermogenic brown and beige adipose tissue in rodents and humans.", "results_summary": "The study found that DHA and fish oil supplementation may reduce waist circumference in humans and attenuate adiposity in rodents, potentially through browning of white adipose tissue and activation of uncoupled respiration in brown fat. The translational potential of these findings for human thermogenic activation remains to be tested.", "population_specificity": "Rodents and humans (based on meta-analyses of dietary intervention studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:28.959841+00:00"}
{"study_id": 187132, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to explore associations between intrauterine DHA exposure and offspring body composition and size at 5 years of age.", "results_summary": "Change in maternal DHA status during pregnancy was associated with higher offspring fat-free mass at 5 years, but no significant effects were found for other body composition measures. Intent-to-treat and DHA status at delivery showed non-significant positive trends for fat-free mass.", "population_specificity": "Offspring of women who participated in the Kansas University DHA Outcomes Study.", "effective_dosage": "600 mg/d DHA supplementation.", "study_duration": "Duration of pregnancy (from enrollment to delivery).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:30.877066+00:00"}
{"study_id": 187128, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess lipid metabolism, including docosahexaenoic acid (DHA) levels, in individuals with phenylketonuria (PKU) consuming different medical foods.", "results_summary": "The study found that PKU participants had lower DHA levels in red blood cells compared to controls, indicating a need for DHA supplementation. No significant differences in DHA levels were observed between the two medical food groups (AA-MFs and GMP-MFs).", "population_specificity": "Adults (aged 18-49 y) and adolescents with early-treated classical and variant PKU, compared to 143 control participants.", "effective_dosage": "Not specified", "study_duration": "3 weeks per intervention (AA-MFs and GMP-MFs)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:31.166169+00:00"}
{"study_id": 187130, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between n-3 PUFAs (including Docosahexaenoic Acid) and cognitive function, particularly in aging and Alzheimer's disease, and the potential benefits of supplementation.", "results_summary": "Observational studies suggest a link between n-3 PUFAs and cognitive aging, while some randomized controlled trials show cognitive benefits, especially in individuals with mild cognitive impairment. The study highlights the need for a biomarker to assess n-3 PUFA intake and tissue levels.", "population_specificity": "Elderly individuals, particularly those with mild cognitive impairment or Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:31.232448+00:00"}
{"study_id": 187129, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to replicate the findings of the DOLAB 1 study to determine if dietary supplementation with DHA improves reading, working memory, and behavior in healthy schoolchildren underperforming in reading.", "results_summary": "The study found no consistent differences in reading, working memory, or behavior between the DHA and placebo groups, though some minor behavioral subscale differences were noted. The results did not replicate the earlier DOLAB 1 study's findings on DHA's effectiveness for learning and behavior.", "population_specificity": "Healthy children aged 7-9 underperforming in reading (<20th centile) from mainstream primary schools in the UK.", "effective_dosage": "600 mg/day DHA (from algal oil)", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:31.293460+00:00"}
{"study_id": 187131, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of fish oil (containing Docosahexaenoic Acid) on gene expression related to insulin action, blood lipids, and inflammation in women with gestational diabetes mellitus (GDM).", "results_summary": "The abstract does not provide specific results regarding the effects of Docosahexaenoic Acid.", "population_specificity": "Women with gestational diabetes mellitus (GDM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:31.640949+00:00"}
{"study_id": 187133, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of docosahexaenoic acid (DHA) on heart rate reduction compared to eicosapentaenoic acid (EPA) through a meta-analysis of clinical trials.", "results_summary": "The meta-analysis found that DHA supplementation significantly reduced heart rate (-2.23 bpm) compared to placebo, with DHA showing a stronger effect than EPA when administered alone. The results were statistically significant and based on a large sample of randomized controlled trials.", "population_specificity": "Approximately 3000 participants across 51 randomized controlled trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:32.928488+00:00"}
{"study_id": 187135, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) supplementation improves quality of life (QOL) in survivors of traumatic injury.", "results_summary": "DHA supplementation did not significantly affect any QOL domain after 12 weeks, but increased erythrocyte levels of EPA and EPA + DHA were associated with better mental component QOL scores in the DHA group.", "population_specificity": "110 trauma patients (82% men; mean age 39.6 years) in an intensive care unit.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:33.107399+00:00"}
{"study_id": 187136, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of 24-month DHA supplementation on cognitive function and amyloid beta-mediated autophagy in elderly subjects with mild cognitive impairment.", "results_summary": "DHA supplementation (2 g/day) significantly improved cognitive function scores (full-scale IQ, verbal IQ, and subdomains) and altered blood biomarkers related to A\u03b2-mediated autophagy, including decreased A\u03b2-42 levels and increased Beclin-1 and LC3-II levels.", "population_specificity": "Elderly individuals with mild cognitive impairment (MCI) in Tianjin, China.", "effective_dosage": "2 g/day", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:37.853189+00:00"}
{"study_id": 187139, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Docosahexaenoic Acid (DHA) could prevent or inhibit acute pancreatitis by reducing oxidative stress and inflammation.", "results_summary": "DHA demonstrated anti-inflammatory and antioxidant effects, activating peroxisome proliferator-activated receptor-\u03b3 and inducing catalase, which inhibited oxidative stress-mediated inflammatory signaling in experimental acute pancreatitis. However, high DHA concentrations were noted to increase cytosolic Ca\u00b2\u207a, suggesting potential risks at elevated doses.", "population_specificity": "Experimental models of acute pancreatitis (cerulein-induced, mimicking human acute pancreatitis-like symptoms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Mentioned potential interaction with statins for reducing hypertriglyceridemic acute pancreatitis.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:40.300301+00:00"}
{"study_id": 187138, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess changes in cortical thickness related to the use of n-3 PUFA (including docosahexaenoic acid) as add-on therapy in patients with first-episode schizophrenia.", "results_summary": "The study found significant differences in cortical thickness loss between the n-3 PUFA and placebo groups in specific brain regions (Brodmann areas 7 and 19 of the left hemisphere), suggesting neuroprotective properties of n-3 PUFA in early-stage schizophrenia. The results align with previous observations in older individuals and patients with mild cognitive impairment.", "population_specificity": "Patients with first-episode schizophrenia.", "effective_dosage": "2.2g/d of combined EPA and DHA.", "study_duration": "26 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:40.694685+00:00"}
{"study_id": 187137, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the associations between maternal docosahexaenoic acid (DHA) status and post-partum cognition, particularly attention and executive function.", "results_summary": "The study found that breastmilk DHA concentrations were positively associated with verbal fluency and digit span forward, suggesting a potential benefit for post-partum cognitive function. However, maternal supplementation with lipid-based nutrient supplements (LNS), which included DHA, did not significantly improve overall cognition or caregiving behavior compared to other interventions.", "population_specificity": "Pregnant and post-partum women in Malawi, including subgroups with baseline low hemoglobin, poor iron status, or malaria.", "effective_dosage": "Not specified (DHA was part of a 20 g/day lipid-based nutrient supplement).", "study_duration": "Supplementation continued until 6 months post-partum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:40.695936+00:00"}
{"study_id": 187142, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether DHA supplementation during pregnancy affects childhood body fat percentage and growth at 7 years of age.", "results_summary": "The study found no significant differences in body fat percentage, BMI, height, weight, or waist/hip circumference between children whose mothers received DHA supplementation and those who received a placebo. These results align with earlier findings from the same cohort at 3 and 5 years.", "population_specificity": "Pregnant women in the second half of gestation and their children followed up to 7 years of age.", "effective_dosage": "800 mg/day DHA", "study_duration": "From 20 weeks' gestation to delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:40.902207+00:00"}
{"study_id": 187143, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation (including DHA) in infancy increases specialized pro-resolving mediators (SPMs) and reduces oxidative stress.", "results_summary": "Omega-3 supplementation from birth to 6 months increased SPM levels at 6 months, particularly 18-HEPE, but these effects were not sustained after supplementation ceased. The study suggests 18-HEPE may be a biologically active metabolite linked to potential health benefits.", "population_specificity": "420 infants from birth to 5 years of age.", "effective_dosage": "280mg DHA and 110mg EPA daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:42.019460+00:00"}
{"study_id": 187144, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of omega-3 fatty acids (DHA and EPA) in reducing ADHD symptoms in children compared to a placebo.", "results_summary": "The study found no beneficial effect of omega-3 supplements on ADHD symptoms, with the placebo group showing greater improvement in ADHD-RS-IV scores. Two severe adverse events (hospitalizations for worsening ADHD symptoms) occurred in the DHA-EPA group.", "population_specificity": "Children aged 6-15 years with an established diagnosis of ADHD, predominantly male (78.4%).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:42.370885+00:00"}
{"study_id": 187141, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a novel SMEDS formulation (PRF-021) of Omega-3-acid EE improves the absorption of EPA and DHA under fasted conditions compared to a control formulation.", "results_summary": "The SMEDS formulation PRF-021 showed 6.4 and 11.5 times higher absorption of EPA and DHA compared to the control in low- and high-dose studies, respectively, under fasted conditions. This indicates significantly enhanced bioavailability without requiring a high-fat meal.", "population_specificity": "Healthy fasted male and female adults.", "effective_dosage": "Low dose: 630 mg EPA + DHA (PRF-021) vs. 840 mg EPA + DHA (control); High dose: 1680 mg EPA + DHA (PRF-021) vs. 3360 mg EPA + DHA (control).", "study_duration": "Single dose with blood sampling over 48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:46.251182+00:00"}
{"study_id": 187145, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the levels of DHA and EPA in cord serum after n-3 FA supplementation during the last trimester of pregnancy.", "results_summary": "Supplementation with DHA/EPA in a 1/1.3 ratio during the last trimester led to higher cord EPA levels compared to the control group, indicating accumulation in the umbilical cord. The decrease in cord EPA levels was significant in the control group but not in the supplement group.", "population_specificity": "55 pregnant women (23 in the supplement group, 29 in the control group).", "effective_dosage": "One capsule daily of n-3 FA supplement (DHA/EPA ratio of 1/1.3).", "study_duration": "Last trimester of pregnancy (approximately 12-14 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:47.698215+00:00"}
{"study_id": 187147, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic benefits of omega-3 PUFAs, including docosahexaenoic acid, in treating major depressive disorder and bipolar disorder, either as monotherapy or adjunct therapy.", "results_summary": "The study found that omega-3 fatty acids, including docosahexaenoic acid, have therapeutic benefits for MDD and bipolar disorder, particularly as adjunct therapy. They also noted that omega-3 supplementation promotes overall health and should be encouraged in primary care settings.", "population_specificity": "Patients with major depressive disorder and bipolar disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:49.436508+00:00"}
{"study_id": 187149, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers sought to evaluate whether prenatal docosahexaenoic acid supplementation, in conjunction with yogurt consumption, was associated with reduced preterm delivery.", "results_summary": "The study found no overall association between prenatal yogurt consumption and preterm delivery, but among nonoverweight women, higher yogurt consumption was associated with reduced preterm delivery. Docosahexaenoic acid's direct effects were not explicitly reported in the abstract.", "population_specificity": "965 pregnant women enrolled in a clinical trial in Mexico.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Midpregnancy enrollment, with yogurt consumption assessed over the previous 3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:49.626939+00:00"}
{"study_id": 187148, "supplement_id": 1089, "safety_score": "100", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of DHA supplementation in improving clinical symptoms and brain functional imaging in patients with Spinocerebellar Ataxia 38 (SCA38).", "results_summary": "DHA supplementation significantly improved clinical symptoms (measured by SARA and ICARS scores) and cerebellar hypometabolism in SCA38 patients after 16 and 40 weeks of treatment, with no reported side effects.", "population_specificity": "10 patients with Spinocerebellar Ataxia 38 (SCA38).", "effective_dosage": "Not specified in the abstract.", "study_duration": "16 weeks (double-blind phase) followed by an additional 24 weeks (open-label phase), totaling 40 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:50.190368+00:00"}
{"study_id": 187146, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to analyze the influence of \u03c9-3 long chain-PUFA (including Docosahexaenoic Acid) on gene expression and blood inflammatory markers in boys with Duchenne Muscular Dystrophy (DMD).", "results_summary": "Supplementation with \u03c9-3 long chain-PUFA significantly reduced proinflammatory markers (NF-\u03baB, IL-1\u03b2, IL-6) and increased anti-inflammatory IL-10 in boys with DMD, demonstrating a beneficial effect on chronic inflammation.", "population_specificity": "Boys with Duchenne Muscular Dystrophy (n = 36).", "effective_dosage": "2.9 g/day of \u03c9-3 long chain-PUFA.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:51.033555+00:00"}
{"study_id": 187150, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the physiological functions and health benefits of docosahexaenoic acid (DHA), particularly its role in cardiovascular disease prevention and overall health.", "results_summary": "The study found that DHA, derived from omega-3 fatty acids, is protective against cardiovascular disease, improves multiple risk factors (e.g., blood pressure, blood lipids), and has antithrombotic, anti-inflammatory, and anti-oxidative effects. It also noted no adverse interactions with medications.", "population_specificity": "General population, with specific mention of individuals with pre-existing cardiovascular disease or elevated blood triglyceride levels.", "effective_dosage": "Not specified (recommendation of at least two oily fish meals per week for general population).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:51.594534+00:00"}
{"study_id": 187151, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess n-3 fatty acid intake, including docosahexaenoic acid (DHA), in the US population across different demographics and evaluate adherence to recommended dietary guidelines.", "results_summary": "The study found that over 90% of the population consumed less than the recommended 0.5 g/day of EPA+DHA from food, with the lowest intake among children, women of childbearing age, and Mexican-Americans. Fish was the primary dietary source for high consumers, but supplement use was low and did not significantly alter median intake.", "population_specificity": "24,621 individuals in the US, categorized by age, sex, and ethnicity, including children, pregnant/lactating women, and Mexican-Americans.", "effective_dosage": "Recommended intake: 0.5 g/day EPA+DHA; median intake: 0.11 g/day; mean intake: 0.17 g/day.", "study_duration": "Data collected from 2003-2008 (cross-sectional analysis).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:55.088109+00:00"}
{"study_id": 187153, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the effects of combined dietary DHA, EPA, and GLA supplementation on sensory processing in toddlers born preterm who exhibited ASD symptoms.", "results_summary": "The study found a medium to large effect size (0.57) for reduction in behaviors associated with sensory sensitivity, though it was not statistically significant (p=0.13). No other scales showed a similar magnitude of effect.", "population_specificity": "31 children aged 18-38 months born at \u226429 weeks' gestation.", "effective_dosage": "Not specified", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:56.115812+00:00"}
{"study_id": 187152, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effectiveness of maternal supplementation with omega-3 LCPUFA (predominantly DHA) until 34 weeks' gestation in reducing the incidence of early preterm birth (EPTB).", "results_summary": "The study found that maternal DHA supplementation resulted in a 50% reduction in the incidence of EPTB and an increase in post-term induction or prelabour caesarean section due to extended gestation. The trial was designed to detect a significant absolute reduction in preterm birth rates with high statistical power.", "population_specificity": "Pregnant women less than 20 weeks' gestation with singleton or multiple pregnancies.", "effective_dosage": "High DHA fish oil capsules (specific dosage not mentioned).", "study_duration": "From enrolment until 34 weeks' gestation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:57.978198+00:00"}
{"study_id": 187154, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the associations between omega-3 fatty acid levels (including docosahexaenoic acid) and anxiety and mental toughness in female collegiate athletes.", "results_summary": "Dietary intake of docosahexaenoic acid was negatively correlated with Beck Anxiety Inventory scores, suggesting a potential link between higher intake and lower general anxiety. No significant correlation was found between docosahexaenoic acid and sport-specific anxiety (SAS-2 scores).", "population_specificity": "54 female collegiate athletes during their off-season.", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:58.125311+00:00"}
{"study_id": 187157, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review existing literature on the role of marine lipids, particularly docosahexaenoic acid (DHA), in preventing or alleviating diet-related chronic diseases using proteomics and lipidomics approaches.", "results_summary": "The abstract highlights that while EPA and DHA have known anti-inflammatory and hypolipidemic properties, their mechanisms of action remain unclear, and meta-analyses have not conclusively supported their health benefits. Modern \"omics\" approaches have provided new insights but are still underutilized in this research area.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:58.261788+00:00"}
{"study_id": 187159, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to quantify the association between changes in the omega-3 index and downstream lipid mediator production in patients with peripheral arterial disease (PAD) taking high-dose n-3 PUFA supplements.", "results_summary": "The study found that oral fish oil supplementation significantly increased the omega-3 index and plasma levels of downstream lipid mediators involved in inflammation resolution, with strong correlations between the omega-3 index and specific mediator increases.", "population_specificity": "Patients with symptomatic peripheral arterial disease (PAD).", "effective_dosage": "4.4 g of fish oil daily.", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:59.433067+00:00"}
{"study_id": 187158, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 72, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of LC-OM3 supplementation (including docosahexaenoic acid) on cardiac death risk and explore reasons for mixed results in prior RCTs.", "results_summary": "The meta-analysis found an 8.0% lower risk of cardiac death in LC-OM3 groups compared to controls, with stronger effects (12.9%-29.1% lower risks) in higher-risk subsets and higher dosages (>1 g/d). The results suggest a modest but statistically significant benefit.", "population_specificity": "71,899 subjects across 14 RCTs, including higher-risk subsets (secondary prevention, elevated triglycerides, LDL cholesterol \u2265130 mg/dL, low statin use).", "effective_dosage": ">1 g/d of eicosapentaenoic acid + docosahexaenoic acid showed larger effects.", "study_duration": "Intervention periods of at least 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:01.010891+00:00"}
{"study_id": 187160, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the \u03a9-3 index as a tool for disease prognosis, focusing on the differential metabolism and effects of EPA and DHA, particularly docosahexaenoic acid (DHA).", "results_summary": "High-dose supplementation with EPA and DHA increased RBC DHA levels, which were associated with decreased liver fat. RBC EPA and DHA were linked to reduced mortality in cardiac disease patients, with EPA showing the strongest association. Dietary \u03b1-linolenic acid increased EPA but not DHA status in middle-aged women.", "population_specificity": "Patients with cardiac disease and middle-aged women.", "effective_dosage": "High-dose supplementation (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:02.382861+00:00"}
{"study_id": 187161, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oral EPA + DHA therapy could reduce PMN activation and improve healing in chronic venous leg ulcers (CVLUs) when added to standard care.", "results_summary": "The study found that EPA + DHA therapy significantly reduced activated PMNs (CD66b+ cells) and showed downward trends in PMN-derived proteases, leading to greater wound area reductions (57% by Day 28, 76% by Day 56) compared to placebo. Reductions in wound area were negatively correlated with PMN markers, suggesting a role in facilitating healing.", "population_specificity": "Patients with chronic venous leg ulcers (CVLUs) receiving standard compression therapy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "56 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:04.733534+00:00"}
{"study_id": 187165, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether EPA and DHA supplementation could protect motor nerve function and reduce muscle damage after eccentric contractions.", "results_summary": "The study found that fish oil supplementation significantly shortened M-wave latency immediately after exercise and may attenuate muscle damage following eccentric contractions.", "population_specificity": "21 men", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:04.857793+00:00"}
{"study_id": 187162, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to explore the feasibility of using 1800 mg of omega-3 PUFAs (including docosahexaenoic acid) for improving depressive symptoms in pregnant women and to compare outcomes between Japan and Taiwan.", "results_summary": "The study found a significant decrease in depressive symptoms in Japanese participants but a smaller improvement in Taiwanese participants, possibly due to differences in population heterogeneity and baseline psychopathology.", "population_specificity": "Pregnant women between 12 and 24 weeks' gestation with depressive symptoms in Japan and Taiwan.", "effective_dosage": "1206 mg eicosapentaenoic acid and 609 mg docosahexaenoic acid daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:05.071071+00:00"}
{"study_id": 187164, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether DHA supplementation could mitigate the neurological and behavioral consequences of n-3 FA deficiency in APOE E4 carriers and potentially prevent or reverse Alzheimer's disease progression.", "results_summary": "The study found that APOE E4 carriers exhibit lower brain DHA levels, which correlate with cognitive impairments like spatial memory loss and increased anxiety. Supplementing with n-3 FA restored brain DHA levels in E4 animals and could potentially delay or reverse AD-related neurological deficits in E4 carriers.", "population_specificity": "APOE E4 allele carriers (both animal models and implied human relevance)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:07.473535+00:00"}
{"study_id": 187163, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of fish oil supplementation (containing docosahexaenoic acid) on infant neurodevelopment and growth at 4 and 6 months of age.", "results_summary": "Fish oil supplementation showed a statistically significant improvement in the communication domain of neurodevelopment at 4 months but no significant effects on other domains or infant growth metrics. The results for other neurodevelopmental domains were inconclusive.", "population_specificity": "Pregnant women aged 18-35 years and their infants (4- and 6-month-olds) in Tabriz, Iran.", "effective_dosage": "120 mg docosahexaenoic acid and 180 mg eicosapentaenoic acid daily.", "study_duration": "From the 20th week of pregnancy until 30 days after childbirth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:09.368223+00:00"}
{"study_id": 187166, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether EPA and DHA supplementation could slow the progression of albuminuria in subjects with coronary artery disease, particularly those with type 2 diabetes.", "results_summary": "EPA and DHA supplementation significantly attenuated the progression of albuminuria in subjects with type 2 diabetes and coronary artery disease, showing a 72.3% increase in ACR in controls versus no significant change in the treatment group. No effect was observed in nondiabetic subjects.", "population_specificity": "262 subjects with stable coronary artery disease (17% women, 30% with type 2 diabetes, mean age 63.3 years).", "effective_dosage": "1.86 g EPA and 1.5 g DHA daily (Lovaza).", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:09.571572+00:00"}
{"study_id": 187167, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of n-3 PUFAs (including Docosahexaenoic Acid) from fish oil or immunonutrition formulas on inflammatory markers in gastric cancer patients.", "results_summary": "The meta-analysis found that n-3 PUFAs supplementation improved albumin and prealbumin levels and reduced IL-6 and TNF-\u03b1 concentrations, but did not affect total protein, transferrin, or CRP levels in gastric cancer patients.", "population_specificity": "Gastric cancer patients, primarily surgical patients (8 studies) and one study on chemotherapy patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:09.837730+00:00"}
{"study_id": 187169, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether LCPUFA supplementation, including docosahexaenoic acid (DHA), improves mood in elderly Japanese men.", "results_summary": "LCPUFA supplementation significantly increased vigor scores (positive mood) compared to placebo, with no significant changes in negative mood scores. Plasma phospholipid levels of DHA and ARA increased in the LCPUFA group.", "population_specificity": "Elderly Japanese men aged 55-64 years.", "effective_dosage": "DHA 300 mg/day, EPA 100 mg/day, ARA 120 mg/day.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:13.055467+00:00"}
{"study_id": 187170, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if nutritional supplementation, including docosahexaenoic acid (DHA), enhances the outcomes of exercise training in COPD patients with low muscle mass.", "results_summary": "The study found that DHA levels increased significantly (+31%) in the supplemented group, alongside improvements in body mass, plasma vitamin D, and physical activity. The nutritional supplementation showed additional benefits on inspiratory muscle strength and physical activity compared to placebo.", "population_specificity": "COPD patients with low muscle mass (51% males, aged 43-80, moderate airflow limitation).", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:13.261073+00:00"}
{"study_id": 187171, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how fish oil supplementation (specifically EPA and DHA) affects lipid profiles in human adipose tissue and identify accurate biomarkers for monitoring oily fish consumption.", "results_summary": "The study found that EPA and DHA were incorporated into highly unsaturated triglycerides, phosphocholines, and phosphoethanolamines in adipose tissue, with phospholipids being the most sensitive biomarkers for this incorporation. Adiposity was also associated with increased highly unsaturated triglycerides due to n-6 PUFA arachidonic acid.", "population_specificity": "66 participants in an n-3 PUFA supplementation study.", "effective_dosage": "Equivalent to zero or four portions of oily fish per week (specific dosage not provided).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:15.155545+00:00"}
{"study_id": 187172, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether 12 months of seal oil omega-3 PUFA supplementation could halt the progression of diabetic sensorimotor polyneuropathy (DSP) in individuals with type 1 diabetes mellitus (T1DM).", "results_summary": "The study found that 12 months of omega-3 supplementation was associated with an increase in corneal nerve fiber length (CNFL) in participants with T1DM, suggesting a potential benefit in slowing DSP progression. However, the study did not report significant clinical outcomes beyond CNFL changes.", "population_specificity": "Individuals with T1DM and evidence of DSP (Toronto Clinical Neuropathy Score \u22651), aged 48 \u00b1 14 years, with a diabetes duration of 27 \u00b1 18 years.", "effective_dosage": "10 mL daily", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:17.321184+00:00"}
{"study_id": 187176, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "To evaluate the effects of omega-3 fatty acids supplementation on cognitive function in Alzheimer's disease patients.", "results_summary": "Most studies did not find statistically significant benefits of omega-3 fatty acids supplementation compared to placebo, though some showed minor improvements in cognitive scales, particularly in very mild AD cases. The effects were insufficient to support supplementation for AD treatment in more severe cases.", "population_specificity": "Humans with Alzheimer's disease (AD), particularly those with very mild AD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:17.739180+00:00"}
{"study_id": 187174, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of omega-3 fatty acids (including DHA) and vitamin D co-supplementation on glucose metabolism and lipid levels in gestational diabetes patients.", "results_summary": "Co-supplementation of vitamin D and omega-3 fatty acids (containing DHA) significantly improved fasting plasma glucose, insulin sensitivity, and lipid profiles compared to placebo or single supplementation. The combined intervention showed the most pronounced benefits.", "population_specificity": "140 gestational diabetes (GDM) patients", "effective_dosage": "1000 mg omega-3 fatty acids (containing 240 mg DHA) twice daily", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:19.440389+00:00"}
{"study_id": 187173, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of EPA and DHA supplementation on the Omega-3 Index (O3I) in individuals with abdominal obesity and subclinical inflammation.", "results_summary": "DHA supplementation significantly increased the O3I more than EPA (+5.6% vs. +3.3% compared to control). DHA also decreased docosapentaenoic acid (DPA) levels, while EPA increased them. The baseline O3I was higher in women than men, but the difference in O3I increase between DHA and EPA was more pronounced in men.", "population_specificity": "48 men and 106 women with abdominal obesity and subclinical inflammation.", "effective_dosage": "2.7g/d of DHA, provided as 3\u00d71g capsules daily.", "study_duration": "10-week treatment phases separated by nine-week washouts.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:20.035264+00:00"}
{"study_id": 187180, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine whether algal DHA supplementation increases DHA concentrations in vegetarian populations.", "results_summary": "All included studies reported that algal DHA significantly improved DHA concentrations and omega-3 indices in vegetarians, though a clear time or dose response was not established due to limited studies.", "population_specificity": "Vegetarian (including vegan) populations", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:21.944641+00:00"}
{"study_id": 187178, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine whether physiological doses of n-3 PUFA (including docosahexaenoic acid) could improve oxidative stress and dyslipidemia in hemodialysis patients.", "results_summary": "Supplementation increased serum n-3 PUFA levels and improved the n-6/n-3 ratio but did not significantly alter lipid or oxidative stress profiles. However, associations were observed between n-3 PUFA and lower isoprostane, advanced oxidation protein product, and higher HDL levels.", "population_specificity": "88 hemodialysis patients aged \u226518 years, on dialysis for at least 6 months.", "effective_dosage": "1.28 g/day of n-3 PUFA.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:24.738488+00:00"}
{"study_id": 187183, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether combining long-chain n-3 PUFAs (EPA and DHA) with pregnancy could enhance immunological tolerance and stimulate endogenous insulin production in women with Type-1 diabetes mellitus (T1DM).", "results_summary": "The study found a statistically significant increase in fasting C-peptide levels (indicating enhanced endogenous insulin production) in the third trimester among pregnant women with T1DM who received EPA and DHA supplementation, compared to the placebo group, which showed no significant change.", "population_specificity": "Pregnant women with Type-1 diabetes mellitus (duration: 5\u201330 years).", "effective_dosage": "EPA 120 mg and DHA 616 mg, twice daily.", "study_duration": "Throughout pregnancy (three trimesters) and after delivery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:28.066435+00:00"}
{"study_id": 187181, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the effect of 1 g daily EPA and DHA supplementation on inflammatory markers and platelet activation in post-myocardial infarction heart failure patients, considering their dietary habits.", "results_summary": "The study found that 1 g daily omega-3 supplementation had no significant effect on lipid or inflammatory parameters except pentraxin 3. The potential benefits were offset by a highly atherogenic diet, suggesting supplementation alone without dietary control is ineffective.", "population_specificity": "30 patients with post-infarction heart failure.", "effective_dosage": "1 g daily (EPA and DHA).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:30.774614+00:00"}
{"study_id": 187184, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of fish oil (containing DHA and EPA) supplementation on nutritional parameters, inflammatory risk, and long-term survival in patients with haematological malignancies during chemotherapy.", "results_summary": "Supplementation increased plasma EPA and DHA levels, reduced C-reactive protein (CRP) and CRP/albumin ratio, and improved long-term survival in patients receiving fish oil compared to the unsupplemented group.", "population_specificity": "Patients with leukaemia or lymphoma undergoing chemotherapy.", "effective_dosage": "2 g/day of fish oil.", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:31.637328+00:00"}
{"study_id": 187187, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of omega-3 polyunsaturated fatty acid (including docosahexaenoic acid) supplementation on clinical cardiovascular events in various high-risk populations.", "results_summary": "The study reviewed large RCTs and meta-analyses, updating prior recommendations for patients with coronary heart disease and offering new recommendations for other high-risk groups, including those with diabetes, prediabetes, and cardiovascular disease. The evidence suggests some benefits in secondary prevention of cardiovascular events.", "population_specificity": "Patients with diabetes mellitus, prediabetes, high risk of cardiovascular disease, prevalent coronary heart disease, stroke, heart failure, and atrial fibrillation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:33.848992+00:00"}
{"study_id": 187185, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether omega 3 polyunsaturated fatty acid supplementation (including docosahexaenoic acid), alone or combined with a multidomain lifestyle intervention, could prevent cognitive decline in elderly individuals with memory complaints.", "results_summary": "The study found no significant effects of docosahexaenoic acid supplementation, either alone or combined with lifestyle interventions, on cognitive decline over 3 years. Adverse events were similar across all groups, indicating no additional safety concerns.", "population_specificity": "Non-demented, community-dwelling adults aged 70+ with memory complaints, limitations in one instrumental activity of daily living, or slow gait speed.", "effective_dosage": "800 mg docosahexaenoic acid and 225 mg eicosapentaenoic acid daily (two capsules).", "study_duration": "3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:34.130247+00:00"}
{"study_id": 187186, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether enteral DHA supplementation at 60 mg/kg/day reduces the risk of bronchopulmonary dysplasia in preterm infants born before 29 weeks of gestation.", "results_summary": "The study found that DHA supplementation did not lower the risk of physiological bronchopulmonary dysplasia and may have increased it compared to the control group. There were no significant differences in death rates or other neonatal illnesses between the two groups.", "population_specificity": "Preterm infants born before 29 weeks of gestation.", "effective_dosage": "60 mg per kilogram of body weight per day.", "study_duration": "Until 36 weeks of postmenstrual age.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:34.192401+00:00"}
{"study_id": 187188, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 45, "quality_score": 85, "study_goal": "To assess whether supplementation of formula milk with LCPUFA (including DHA) is safe and beneficial for full-term infants, focusing on visual function, neurodevelopment, and physical growth.", "results_summary": "Most RCTs showed no beneficial effects or harms of LCPUFA supplementation on neurodevelopmental outcomes, and no consistent benefits on visual acuity. Meta-analysis of three RCTs indicated a modest benefit for visual acuity at 12 months.", "population_specificity": "Full-term infants fed formula milk.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:36.805610+00:00"}
{"study_id": 187189, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether acute ingestion of DHA, combined with choline and uridine, enhances anaerobic exercise performance and cognition.", "results_summary": "The study found no significant difference between the supplement and placebo on anaerobic performance or neural cognition, suggesting no acute benefit from the tested formulation. The authors hypothesized that longer-term supplementation might be necessary for observable effects.", "population_specificity": "Twenty college-aged trained males (21.2\u00b11.4 years, 181.2\u00b16.1 cm, 94.4\u00b120.5 kg, 15.9\u00b16.6% body fat).", "effective_dosage": "1500 mg DHA (single dose, combined with 500 mg AGPC and 250 mg uridine-5'-monophosphate).", "study_duration": "Acute (single dose, 90 minutes before testing).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:41.764506+00:00"}
{"study_id": 187190, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 12 weeks of fish oil supplementation (containing DHA) affects resting metabolic rate and substrate oxidation in healthy young males compared to an olive oil control.", "results_summary": "The study found no significant changes in resting metabolic rate or substrate oxidation after fish oil supplementation. However, seasonal effects were observed, with increased fatty acid oxidation and decreased carbohydrate oxidation during winter, unrelated to supplementation.", "population_specificity": "Healthy young males (n = 26; age 22.8 \u00b1 2.6 years).", "effective_dosage": "1 g/d docosahexaenoic acid (DHA) as part of a 3 g/d fish oil supplement.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:42.476092+00:00"}
{"study_id": 187193, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of n-3 ingestion, including docosahexaenoic acid (DHA), on periodontal disease and its relationship with plasma concentrations of fatty acids.", "results_summary": "The study found no significant difference in periodontal disease severity with n-3 supplementation, but lower disease severity was observed in patients with higher n-3 levels from their usual diet. A preventive effect of EPA and DHA against periodontal disease progression was detected.", "population_specificity": "Humans with periodontal disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:42.977896+00:00"}
{"study_id": 187192, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of low-dose omega-3 PUFAs, including docosahexaenoic acid, on salivary markers and clinical parameters in patients with chronic periodontitis when used alongside scaling and root planing.", "results_summary": "The study found that low-dose omega-3 PUFAs significantly reduced salivary TNF-\u03b1 levels at 6 months but did not significantly affect clinical parameters or SOD levels compared to the placebo group. The systemic benefits of omega-3 PUFAs did not translate to measurable improvements in periodontal health.", "population_specificity": "Thirty systemically healthy subjects with chronic periodontitis.", "effective_dosage": "19.19 mg docosahexaenoic acid (combined with 6.25 mg eicosapentaenoic acid).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:44.372278+00:00"}
{"study_id": 187191, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if high-dose DHA supplementation could reduce early preterm birth (<34 weeks) and identify subsets of pregnancies most likely to benefit.", "results_summary": "The study proposes that high-dose DHA supplementation (1000 mg/d) may reduce early preterm birth by up to 75%, with a Bayesian adaptive design to optimize efficacy assessment. Safety and delivery outcomes were monitored, but specific results are not detailed in the abstract.", "population_specificity": "Pregnant women \u226518 years old, between 12-20 weeks gestation, recruited from three academic medical institutions.", "effective_dosage": "Experimental group: 1000 mg DHA/d (800 mg from algal oil + 200 mg from prenatal supplement); control group: 200 mg DHA/d (from prenatal supplement only).", "study_duration": "From enrollment (12-20 weeks gestation) through pregnancy and delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:44.733757+00:00"}
{"study_id": 187194, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of fish oil supplementation (containing DHA and EPA) on pregnancy outcomes, including birth weight and maternal serum DHA levels.", "results_summary": "Fish oil supplementation slightly increased birth weight (not statistically significant) and significantly reduced low birth weight incidence. Maternal serum DHA levels were higher in the intervention group, but other maternal outcomes showed no significant differences.", "population_specificity": "150 pregnant women aged 18-35 years in Tabriz, Iran.", "effective_dosage": "1000 mg fish oil (180 mg EPA and 120 mg DHA) daily.", "study_duration": "From week 20 of gestation to birth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:46.410678+00:00"}
{"study_id": 187195, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of EPA and DHA supplementation on inflammatory gene expression in individuals at risk for cardiometabolic diseases.", "results_summary": "The study found no significant difference between EPA and DHA in inflammatory gene expression. Both EPA and DHA modulated specific genes (e.g., PPARA, CD14) compared to control, with stronger correlations for anti-inflammatory genes.", "population_specificity": "154 men and women with abdominal obesity and low-grade inflammation.", "effective_dosage": "2.7 g/d of DHA.", "study_duration": "10 weeks per supplementation phase.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:51.904973+00:00"}
{"study_id": 187196, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare clinical outcomes in neonates receiving soybean oil-based IVFEs versus new-generation IVFEs containing docosahexaenoic acid (DHA) to determine if the latter improved morbidity-related outcomes.", "results_summary": "The study suggests that new-generation IVFEs with higher DHA content, lower \u03c9-6 fatty acids, and reduced phytosterols may improve outcomes in neonates, potentially reducing morbidities like liver disease and impaired neurodevelopment compared to soybean oil-based IVFEs. However, the abstract does not provide specific statistical results or effect sizes.", "population_specificity": "Neonates, particularly preterm infants receiving parenteral nutrition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:51.911506+00:00"}
{"study_id": 187197, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the relationship between docosahexaenoic acid (DHA) and calgranulin gene expression during inflammation, particularly in adipose tissue and circulating cells.", "results_summary": "The study found that n-3 PUFA supplementation (including DHA) led to increased calgranulin gene expression in adipose tissue but decreased expression in circulating cells during endotoxemia, suggesting a cell-specific anti-inflammatory effect. The response was significantly greater in the n-3 PUFA group compared to placebo.", "population_specificity": "Subjects in the FFAME Study (n=14 total; 8 receiving n-3 PUFA, 6 placebo) undergoing evoked endotoxemia.", "effective_dosage": "3600 mg/day EPA/DHA combined.", "study_duration": "6-8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:54.053609+00:00"}
{"study_id": 187199, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of Omega-3 fatty acids (including docosahexaenoic acid) supplementation on serum irisin levels in men with coronary artery disease (CAD).", "results_summary": "Omega-3 fatty acids supplementation increased serum irisin and decreased hs-CRP and LDL cholesterol, but did not significantly affect anthropometric measurements, blood pressure, most serum lipids, fasting blood glucose, body composition, or insulin levels.", "population_specificity": "Male patients with CAD and more than 50% stenosis in at least one major coronary vessel.", "effective_dosage": "720 mg eicosapentaenoic acid plus 480 mg docosahexaenoic acid daily.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:54.134425+00:00"}
{"study_id": 187198, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether high-dose DHA supplementation in APOE4 carriers before the onset of Alzheimer's disease (AD) dementia could reduce the risk or delay the onset of AD symptoms.", "results_summary": "The study found that DHA supplementation may slow early memory decline in APOE4 carriers during the predementia stage of AD but showed mixed results in symptomatic AD. Early \u03c9-3 supplementation could reduce the risk or delay AD symptoms in APOE4 carriers, while efficacy in AD dementia was limited due to accelerated DHA catabolism.", "population_specificity": "APOE4 allele carriers at risk for or in the predementia stage of Alzheimer's disease.", "effective_dosage": "High-dose (specific amount not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:54.491039+00:00"}
{"study_id": 187200, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of n-3PUFAs, including docosahexaenoic acid (DHA), on affective disorders such as major depression, bipolar disorder, and perinatal depression.", "results_summary": "The study found that n-3PUFAs supplementation might have clinical benefits on depressive symptoms, but EPA was more effective than DHA in treating major depression. DHA showed no significant efficacy in perinatal depression.", "population_specificity": "Patients with depressive symptoms, including those with unipolar or bipolar disorder and pregnant women with depressive symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:54.971610+00:00"}
{"study_id": 187177, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine factors associated with a favorable response to fish oil treatment (including docosahexaenoic acid) and characterize changes in red blood cell polyunsaturated fatty acids following supplementation.", "results_summary": "High-dose n-3 PUFA supplementation significantly increased the omega-3 index, particularly in patients with lower BMI and higher LDL cholesterol levels, while reducing n-6 PUFA content in red blood cells. No significant changes were observed in the placebo group.", "population_specificity": "Patients with mild to severe peripheral arterial disease (claudication).", "effective_dosage": "1.8 g docosahexaenoic acid daily (as part of 4.4 g total fish oil).", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:57.766507+00:00"}
{"study_id": 187201, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the role of dietary omega-3 PUFA deficiency, particularly docosahexaenoic acid (DHA), in the pathophysiology of mood disorders and the potential benefits of supplementation.", "results_summary": "The study found that low blood levels of n-3 PUFA, including DHA, are associated with increased risk for mood disorders and that supplementation can correct this deficit and may have antidepressant effects. Perinatal deficiency in n-3 PUFA was also linked to neuropathological and behavioral features resembling mood disorders.", "population_specificity": "Patients with mood disorders (e.g., major depressive disorder, bipolar disorder) and general populations with dietary n-3 PUFA insufficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:01.975494+00:00"}
{"study_id": 187202, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether \u03c9-3 supplementation, including docosahexaenoic acid, improves cardiometabolic profiles in individuals with cardiovascular risk factors and how adiponectin levels influence these changes.", "results_summary": "The \u03c9-3 group showed increased serum adiponectin, with greater improvements in lipid profiles and glucose metabolism in participants with lower baseline adiponectin. Higher adiponectin variation correlated with reduced cardiovascular risk scores.", "population_specificity": "80 individuals (both sexes, mean age 52 years) with at least one cardiovascular risk factor (excess weight, hypertension, dyslipidemia, diabetes, or smoking).", "effective_dosage": "3 g/d of fish oil (37% eicosapentaenoic acid and 23% docosahexaenoic acid).", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:02.779973+00:00"}
{"study_id": 187205, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether maternal DHA supplementation during pregnancy affects nonfasting serum lipid and glucose concentrations in offspring at 4 years of age.", "results_summary": "The study found no significant differences in nonfasting serum lipid and glucose concentrations between offspring of mothers who received DHA supplementation and those who received a placebo, indicating no effect of prenatal DHA supplementation on these metabolic outcomes.", "population_specificity": "Pregnant women in Mexico and their offspring.", "effective_dosage": "400 mg DHA daily.", "study_duration": "From 18-22 weeks of gestation to delivery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:03.544738+00:00"}
{"study_id": 187204, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of DHA-enriched fish oil supplementation on telomerase activity, P16 mRNA expression, and inflammatory markers in type 2 diabetic patients with PPAR\u03b3 Pro12Ala polymorphism.", "results_summary": "The study found that DHA supplementation decreased telomerase activity and increased P16 mRNA expression, suggesting a potential link to cellular senescence, but did not significantly affect TNF-\u03b1 or IL-6 mRNA expression. The Pro12Ala polymorphism did not modulate these effects.", "population_specificity": "72 type 2 diabetic patients aged 30-70 years with PPAR\u03b3 Pro12Ala polymorphism.", "effective_dosage": "2.4 grams of DHA-enriched fish oil daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:03.556974+00:00"}
{"study_id": 187206, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) could attenuate muscle function declines caused by immobilization.", "results_summary": "DHA supplementation (combined with EPA) showed a non-significant trend toward reducing torque declines during immobilization, but no significant effects on muscle fatigue, co-contraction, or blood flow were observed. All parameters returned to baseline after re-mobilization.", "population_specificity": "24 healthy male and female participants, aged 23.0\u00b15.8 years.", "effective_dosage": "390 mg DHA daily (combined with 1770 mg EPA).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:04.109221+00:00"}
{"study_id": 187203, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplementation with n-3 LCPUFAs (including docosahexaenoic acid) during pregnancy reduces the risk of persistent wheeze and asthma in offspring.", "results_summary": "Supplementation with n-3 LCPUFAs reduced the risk of persistent wheeze or asthma by 30.7% and lowered the risk of lower respiratory tract infections, with the strongest effects observed in women with low baseline levels of these fatty acids. No significant association was found for asthma exacerbations, eczema, or allergic sensitization.", "population_specificity": "Pregnant women at 24 weeks of gestation and their offspring.", "effective_dosage": "2.4 g of n-3 LCPUFA (fish oil) per day.", "study_duration": "From 24 weeks of gestation until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:04.729608+00:00"}
{"study_id": 187207, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA), combined with eicosapentaenoic acid (EPA), could attenuate muscle loss and other changes induced by short-term limb immobilization.", "results_summary": "The \u03c9-3 supplementation group (containing DHA) showed non-significant trends toward attenuating muscle thickness, arm girth, and lean mass losses compared to placebo, with a notable blunting of increased subcutaneous adipose thickness. All parameters returned to baseline after re-mobilization.", "population_specificity": "24 healthy male and female participants, aged 23.0\u00b15.8 years.", "effective_dosage": "390 mg DHA daily (combined with 1770 mg EPA).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:08.070843+00:00"}
{"study_id": 187210, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether moderate intake of docosahexaenoic acid (DHA) could reduce oxidative stress and improve antioxidant status in patients with cystic fibrosis.", "results_summary": "DHA supplementation increased DHA levels in plasma and platelets and significantly raised vitamin E amounts, but lipid peroxidation markers did not significantly decrease despite a trend. The findings suggest DHA has antioxidant potential in subjects with elevated oxidative stress.", "population_specificity": "10 patients with cystic fibrosis", "effective_dosage": "5mg/kg daily for 2 weeks, then 10mg/kg daily for the next 2 weeks", "study_duration": "4 weeks per phase (with a 9-week wash-out between phases)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:11.584165+00:00"}
{"study_id": 187213, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of DHA supplementation during pregnancy, lactation, and infancy on neurodevelopment in healthy children.", "results_summary": "Observational studies linked DHA intake in pregnancy to offspring neurodevelopment, but clinical trials found no consistent benefit or harm from DHA supplementation in healthy term infants or pregnant/lactating women. The evidence does not support DHA supplementation for these groups.", "population_specificity": "Healthy pregnant and lactating women, and healthy term infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:11.993603+00:00"}
{"study_id": 187211, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate how child diet, maternal socioeconomic status, and prenatal DHA supplementation interact to influence health outcomes.", "results_summary": "The study identified two major dietary patterns (\"Prudent\" and \"Western\") in young children and found that a Prudent diet was associated with higher maternal SES. The interaction between prenatal DHA supplementation and these factors was noted as an important area for further investigation.", "population_specificity": "Young US children (ages 2-4.5 years) from a cohort of 190 participants in a randomized, controlled trial of prenatal DHA supplementation.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Diets were recorded at 6-month intervals from 2-4.5 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:13.244980+00:00"}
{"study_id": 187214, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the molecular mechanisms behind the neuroprotective potential of DHA, particularly in Alzheimer's disease (AD), based on animal and cell culture studies.", "results_summary": "The study found that DHA plays a critical role in brain function, with reduced levels observed in AD patients. Animal, epidemiological, preclinical, and clinical studies indicated DHA's neuroprotective effects in neurodegenerative conditions, including AD, though its benefits may depend on disease stage, dietary mediators, and ApoE genotype.", "population_specificity": "Animal models, cell cultures, and human epidemiological/clinical studies (including AD patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:13.302682+00:00"}
{"study_id": 187209, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of docosahexaenoic acid (DHA) on cognitive decline, including Alzheimer's disease, in older adults based on recent human studies.", "results_summary": "Higher fish intake was associated with preserved cognition in community-dwelling patients, and DHA supplementation improved cortical blood flow in older adults with memory complaints. However, a 5-year intervention showed no cognitive benefits, and a Cochrane review found no 6-month benefit in mild/moderate Alzheimer's patients.", "population_specificity": "Older adults, including those with memory complaints, mild cognitive impairment, and mild/moderate Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Varied (5-year intervention, 6-month review)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:13.386298+00:00"}
{"study_id": 187208, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to assess whether supplementation of formula milk with LCPUFA, including docosahexaenoic acid (DHA), is safe and beneficial for preterm infants, focusing on visual function, development, and growth.", "results_summary": "The study found no clear long-term benefits or harms of LCPUFA supplementation in preterm infants, with mixed results on visual acuity, neurodevelopment, and physical growth. Meta-analyses showed no significant effects on neurodevelopment at 12 or 18 months, and inconsistent effects on growth outcomes.", "population_specificity": "Relatively mature and healthy preterm infants (median gestational age: 30 weeks; median birth weight: 1300 g).", "effective_dosage": "Median DHA concentration: 0.33% (range: 0.15% to 1%); arachidonic acid (AA) concentration: 0.37% (range: 0.02% to 0.84%).", "study_duration": "Varied across studies, with follow-up assessments at 12 and 18 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:13.582253+00:00"}
{"study_id": 187215, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to determine whether maternal DHA supplementation during pregnancy could alter the infant epigenome, specifically focusing on DNA methylation patterns.", "results_summary": "Maternal DHA supplementation resulted in small DNA methylation differences (<5%) in infants at birth, with 21 differentially methylated regions (DMRs) identified. Some effects appeared gender-specific, with more DMRs in males (127) than females (72), and some persisted until 5 years of age.", "population_specificity": "Pregnant mothers and their infants.", "effective_dosage": "800 mg DHA/day.", "study_duration": "From 20 weeks' gestation to delivery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:16.740906+00:00"}
{"study_id": 187217, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of DHA dietary supplementation on semen quality, fatty acid composition, antioxidant capacity, and DNA fragmentation.", "results_summary": "The study found no changes in traditional sperm parameters or lipid composition but observed increased DHA and Omega-3 content in seminal plasma, improved antioxidant status, and reduced sperm DNA damage in the DHA group.", "population_specificity": "57 male subjects (25 placebo, 32 DHA group)", "effective_dosage": "1,500 mg/day of DHA-enriched oil (three 500-mg capsules daily)", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:20.330260+00:00"}
{"study_id": 187216, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prenatal DHA supplementation affects specific cognitive domains in infants, particularly attention and habituation.", "results_summary": "DHA supplementation did not impact look duration or habituation parameters but maintained high levels of sustained attention in infants, while attention declined in the placebo group. The supplemented group also showed reduced attrition on habituation tasks, especially at 6 and 9 months.", "population_specificity": "Pregnant women and their infants.", "effective_dosage": "600 mg/d DHA.", "study_duration": "Last two trimesters of pregnancy.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:20.771330+00:00"}
{"study_id": 187219, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore whether nutritional supplementation of docosahexaenoic acid (DHA) could preserve membrane organization and prevent cognitive decline associated with aging.", "results_summary": "The study suggests that alterations in brain lipid composition impact membrane properties and microdomain functionality, and that DHA supplementation may help preserve cerebral function by maintaining membrane organization. However, it does not establish a direct cause-and-effect relationship between DHA and cognitive outcomes.", "population_specificity": "General aging population (not specified further).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:21.668711+00:00"}
{"study_id": 187221, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of DHA supplementation on cognitive function and hippocampal atrophy in elderly subjects with mild cognitive impairment (MCI).", "results_summary": "DHA supplementation (2\u200ag/day) for 12 months significantly improved cognitive function (Full-Scale IQ, Information, Digit Span) and slowed hippocampal atrophy (left, right, total hippocampus, and global cerebrum volumes) compared to placebo.", "population_specificity": "Elderly individuals (aged 65+) with mild cognitive impairment (MCI) in Tianjin, China.", "effective_dosage": "2\u200ag/day", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:21.856278+00:00"}
{"study_id": 187212, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the relationship between prenatal omega-3 LCPUFA (including Docosahexaenoic Acid) supplementation and the incidence of preterm birth.", "results_summary": "The study suggests that omega-3 LCPUFA supplementation may delay the timing of birth and could serve as a prophylactic intervention for some women, based on randomized controlled trials and epidemiological observations.", "population_specificity": "Pregnant women, particularly those at risk of preterm birth.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:22.125681+00:00"}
{"study_id": 187218, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine if n-3 LCPUFA (specifically DHA) decreases markers of NAFLD, compare the efficacies of EPA and DHA, and identify factors contributing to discrepancies in results.", "results_summary": "The study found that n-3 LCPUFA supplementation, particularly DHA, reduced liver fat, liver enzymes, and markers of inflammation in NAFLD patients. DHA was more effective than EPA, and combining caloric restriction with n-3 LCPUFA further decreased hepatic steatosis.", "population_specificity": "Patients with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH).", "effective_dosage": "DHA 250 mg/day to a mixture of EPA+DHA 50 mL/day.", "study_duration": "8 weeks to 2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:23.411574+00:00"}
{"study_id": 187220, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether LCPUFA (including DHA) supplementation in infancy affects brain electrophysiology and behavioral outcomes related to response inhibition at 5.5 years of age.", "results_summary": "LCPUFA-supplemented children showed marginally faster reaction times and distinct brain activation patterns (higher P2 amplitude, N2 amplitude differences, and novel microstate development) compared to controls, suggesting developmental programming effects on brain function. Behavioral measures did not differ significantly between groups.", "population_specificity": "69 newborns randomly assigned to control or supplemented formula groups, assessed at 5.5 years.", "effective_dosage": "0.32%, 0.64%, or 0.96% of total fatty acids as DHA (with 0.64% ARA).", "study_duration": "First 12 months of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:23.486387+00:00"}
{"study_id": 187222, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of 8-week training and DHA supplementation on mitochondrial dynamics and antioxidant status in PBMCs from sportsmen.", "results_summary": "The abstract does not provide specific results regarding DHA's effects, only stating the aim of the study.", "population_specificity": "Sportsmen", "effective_dosage": "1.14 g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:23.906593+00:00"}
{"study_id": 187223, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the efficacy of omega-3 PUFA supplementation, including docosahexaenoic acid, in reducing depressive symptoms in pregnant women in Taiwan and Japan.", "results_summary": "The study protocol outlines a randomized controlled trial to evaluate the effects of omega-3 PUFAs on depressive symptoms, with primary outcomes measured at 12 weeks. Results are not yet reported in the abstract, but the study is designed to detect a clinically meaningful difference in depression scores.", "population_specificity": "Pregnant women with depressive symptoms in Taiwan and Japan.", "effective_dosage": "600 mg docosahexaenoic acid daily (combined with 1,200 mg eicosapentaenoic acid).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:30.326079+00:00"}
{"study_id": 187226, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of docosahexaenoic acid (DHA) in regulating inflammatory responses and its potential for preventing inflammation-associated cancer and metabolic disorders.", "results_summary": "The study found that DHA, as a precursor of proresolving lipid mediators, facilitates the resolution of inflammation by promoting efferocytosis and regulating leukocyte activity, suggesting its preventive potential in chronic inflammation-related malignancies.", "population_specificity": "Not specified (general human pathophysiology context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:30.663539+00:00"}
{"study_id": 187227, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if hospital costs differed between groups receiving 600mg DHA per day versus placebo, focusing on early preterm birth reduction and associated healthcare savings.", "results_summary": "The study found that DHA supplementation (600mg/day) significantly reduced early preterm births and resulted in a net hospital cost saving of $1484 per mother-infant dyad, with potential annual US healthcare savings of up to $6 billion if universally adopted.", "population_specificity": "Pregnant women and their infants (197 mother-infant dyads) delivering at Kansas University Hospital.", "effective_dosage": "600mg DHA per day.", "study_duration": "26 weeks (last two trimesters of pregnancy).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.073923+00:00"}
{"study_id": 187224, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid (\u03c93-FA) supplementation, including docosahexaenoic acid, improves arterial stiffness and blood pressure in adults with familial hypercholesterolaemia (FH) on statin therapy.", "results_summary": "\u03c93-FA supplementation significantly improved large artery elasticity (+9%), reduced systolic and diastolic blood pressure (-6% each), and lowered plasma triglycerides (-20%) and apoB concentration (-8%), but had no effect on small artery elasticity.", "population_specificity": "20 adults with familial hypercholesterolaemia (FH) on optimal cholesterol-lowering therapy.", "effective_dosage": "4 g/d \u03c93-FA (46% eicosapentaenoic acid and 38% docosahexaenoic acid).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.120674+00:00"}
{"study_id": 187225, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of DHA-enriched fish oil on markers of monocyte/macrophage activation (sCD163), vascular function (ADMA), and insulin resistance in type 2 diabetic patients.", "results_summary": "DHA-enriched fish oil significantly reduced serum sCD163, triglycerides, waist circumference, and weight-to-height ratio in type 2 diabetic patients, with no significant between-group differences in ADMA levels. The improvements in sCD163, triglycerides, and anthropometric measures remained significant after controlling for confounders.", "population_specificity": "Type 2 diabetic patients aged 30-70 years with a BMI of 18.5 to 40 kg/m\u00b2.", "effective_dosage": "2.4 g DHA-enriched fish oil per day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.626594+00:00"}
{"study_id": 187229, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 25, "quality_score": 65, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids, including docosahexaenoic acid (DHA), improve insulin resistance in women with polycystic ovary syndrome (PCOS).", "results_summary": "The meta-analysis found no significant effect of omega-3 fatty acid supplementation on insulin resistance or HOMA-IR in women with PCOS, suggesting no beneficial impact.", "population_specificity": "Women with polycystic ovary syndrome (PCOS)", "effective_dosage": "1.2g to 3.6g of omega-3 supplements (including DHA and EPA)", "study_duration": "6 to 8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.683738+00:00"}
{"study_id": 187230, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of docosahexaenoic acid (DHA) on clinical and intermediate cardiovascular outcomes and its association with cardiovascular disease.", "results_summary": "The study found moderate evidence that purified DHA supplementation has no effect on blood pressure or LDL-c, and low evidence of no association between DHA intake and coronary heart disease or atrial fibrillation. Limited data were available on DHA's effect on clinical cardiovascular outcomes.", "population_specificity": "Healthy adults, those at risk for cardiovascular disease, or those with cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "Minimum 4 weeks for intermediate outcomes, 1 year or more for clinical outcomes.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:33.254829+00:00"}
{"study_id": 187228, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of \u03c9-3 FAEE supplementation (containing docosahexaenoic acid) on postprandial triglyceride and lipoprotein responses in familial hypercholesterolemia patients.", "results_summary": "\u03c9-3 FAEE supplementation significantly reduced fasting and postprandial plasma triglycerides, VLDL-apoB-100, and apoB-48 levels, as well as systolic and diastolic blood pressure in FH patients.", "population_specificity": "Familial hypercholesterolemia patients receiving standard cholesterol-lowering treatment.", "effective_dosage": "4 g/d \u03c9-3 FAEE (46% eicosapentaenoic acid and 38% docosahexaenoic acid).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:33.385440+00:00"}
{"study_id": 187231, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of oral re-esterified omega-3 fatty acids, including docosahexaenoic acid, on dry eye symptoms and related biomarkers in subjects with meibomian gland dysfunction.", "results_summary": "The study found that docosahexaenoic acid supplementation significantly improved tear osmolarity, omega-3 index levels, tear break-up time, MMP-9 positivity, and OSDI symptom scores compared to the control group.", "population_specificity": "Subjects with dry eyes and confirmed meibomian gland dysfunction.", "effective_dosage": "560 mg docosahexaenoic acid daily (total 1680 mg eicosapentaenoic acid/560 mg docosahexaenoic acid across 4 softgels).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:40.144619+00:00"}
{"study_id": 187234, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate associations between neonatal DHA and AA levels in the umbilical cord and cardiometabolic health (blood pressure and anthropometrics) at age 9.", "results_summary": "The study found no association between DHA levels and systolic or diastolic blood pressure at age 9. However, higher AA levels and a higher AA:DHA ratio at birth were associated with lower diastolic blood pressure at age 9.", "population_specificity": "229 children who participated in a randomized controlled trial on LCPUFA formula supplementation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:40.830809+00:00"}
{"study_id": 187235, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine whether APOE \u025b4 genotype and low CSF A\u03b242 levels were associated with reduced delivery of DHA to CSF in a clinical trial.", "results_summary": "The study found that APOE \u025b4 carriers and those with lower baseline CSF A\u03b242 levels had less DHA transport to CSF after supplementation. Participants in the lowest A\u03b242 tertile showed significantly lower CSF DHA levels and CSF-to-plasma DHA ratios compared to other tertiles.", "population_specificity": "384 participants (70 with CSF measurements) in the Alzheimer's Disease Cooperative Study-sponsored DHA clinical trial, including APOE \u025b4 carriers and non-carriers.", "effective_dosage": "Not specified in the abstract.", "study_duration": "18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:40.890885+00:00"}
{"study_id": 187233, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of DHA supplementation on vascular function, telomerase activity, and the PPAR\u03b3-LXR\u03b1-ABCA1 pathway in type 2 diabetes mellitus patients, based on genetic polymorphism.", "results_summary": "The abstract does not provide specific results, but the study design suggests an investigation into DHA's potential benefits on metabolic and vascular parameters in T2DM patients with genetic variations.", "population_specificity": "72 type 2 diabetes mellitus patients (30-70 years old, BMI 18.5-35 kg/m\u00b2), stratified by Pro12Ala polymorphism in PPAR\u03b3.", "effective_dosage": "2.4 g/day DHA", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:40.904555+00:00"}
{"study_id": 187236, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily buccal DHA and ARA supplementation could increase blood levels of these fatty acids in extremely-low-birth-weight infants.", "results_summary": "The study found no significant differences in DHA or ARA levels between supplemented and placebo groups at 2 or 8 weeks, though DHA levels increased by 31% over time in all infants. ARA levels remained unchanged.", "population_specificity": "Extremely-low-birth-weight (ELBW) infants with a median birth weight of 806 g.", "effective_dosage": "DHA 20 mg/kg/d + ARA 40 or 60 mg/kg/d, or ARA 120 mg/kg/d.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:41.106587+00:00"}
{"study_id": 187232, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 polyunsaturated fatty acids, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), could modulate age-related cardiovascular responses during isometric handgrip exercise.", "results_summary": "The study found that fish oil supplementation attenuated increases in mean arterial pressure (MAP) and diastolic blood pressure (DBP) during handgrip exercise in both young and older adults, while also enhancing pulse pressure (PP) responses. However, it did not significantly affect systolic blood pressure (SBP) or heart rate (HR) changes.", "population_specificity": "Healthy young (25 \u00b1 1 years) and older (64 \u00b1 2 years) adults.", "effective_dosage": "4 g fish oil daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:41.239880+00:00"}
{"study_id": 187237, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of long-chain polyunsaturated fatty acid (including docosahexaenoic acid) supplementation on neurodevelopment outcomes in preterm infants.", "results_summary": "The meta-analysis found a significant improvement in neurodevelopment, as measured by the Mental Development Index of the Bayley Scales at one to three years of age, in preterm infants receiving supplementation compared to controls. However, the final developmental outcome may remain unchanged.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:41.516299+00:00"}
{"study_id": 187238, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to test the effectiveness of prenatal DHA supplementation on birth outcomes and infant development in African American women living in low-income urban environments.", "results_summary": "Infants of mothers who received DHA had higher birth weight, better Apgar scores, and lower cortisol response to stress compared to placebo. No differences were found in BSID-III scores between groups.", "population_specificity": "Pregnant African American women with Medicaid insurance living in Pittsburgh.", "effective_dosage": "450mg/day of DHA", "study_duration": "From enrollment (16-21 weeks gestation) through delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:42.125180+00:00"}
{"study_id": 187241, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to summarize current knowledge and evaluate the therapeutic value of EPA and DHA supplementation for improving insulin sensitivity in humans, while discussing potential mechanisms of action in target tissues.", "results_summary": "Recent studies suggest beneficial effects of n-3 PUFA on insulin sensitivity in rodents, but human intervention studies largely fail to demonstrate benefits in type 2 diabetes or insulin-resistant non-diabetic individuals. Observational human studies are encouraging, but significant discordance remains between animal and human findings.", "population_specificity": "Rodents and humans (type 2 diabetes or insulin-resistant non-diabetic individuals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:49.668256+00:00"}
{"study_id": 187242, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementary DHA reduces the rate of bronchopulmonary dysplasia (BPD) in infants born at less than 29 weeks' gestation.", "results_summary": "The study design suggests potential benefits of DHA in reducing BPD, but specific efficacy results are not provided in the abstract. The trial is powered to detect a clinically meaningful reduction in BPD incidence.", "population_specificity": "Very preterm infants born at less than 29 weeks' gestation.", "effective_dosage": "60 mg/kg/day of DHA.", "study_duration": "Until 36 weeks' postmenstrual age (PMA).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:49.671668+00:00"}
{"study_id": 187243, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To determine if prenatal DHA supplementation affects PUFA concentrations in the breast milk of Chinese lactating women.", "results_summary": "DHA intake >185 mg/day significantly increased DHA concentrations in breast milk compared to the control group, suggesting dietary or supplemental DHA can meet infant nutritional needs.", "population_specificity": "Chinese lactating women during 1-month postpartum care.", "effective_dosage": "Three levels: <57 mg/day, 57-185 mg/day, >185 mg/day.", "study_duration": "Prenatal supplementation duration not specified; breast milk samples collected between 22nd-25th day postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:49.675961+00:00"}
{"study_id": 187239, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of EPA and DHA supplementation on inflammation markers and blood lipids in individuals at risk of cardiovascular disease.", "results_summary": "DHA was more effective than EPA in reducing interleukin-18 (IL-18) and increasing adiponectin, while also showing greater improvements in blood lipids, including triglycerides, HDL cholesterol, and LDL cholesterol. However, changes in CRP, IL-6, and tumor necrosis factor-\u03b1 were not significantly different between DHA and EPA.", "population_specificity": "Healthy men (n = 48) and women (n = 106) with abdominal obesity and low-grade systemic inflammation.", "effective_dosage": "2.7 g/d of DHA (re-esterified triacylglycerol; 90% pure).", "study_duration": "10 weeks per supplementation period, with 9-week washout periods between interventions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:51.297116+00:00"}
{"study_id": 187244, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prenatal supplementation with n-3 LCPUFA (specifically DHA and EPA) reduced IgE-associated allergic disease in 6-year-old children with a family history of allergic disease.", "results_summary": "Prenatal n-3 LCPUFA supplementation did not reduce IgE-associated allergic disease at 6 years of age but showed a modest reduction in sensitization to house dust mite Dermatophagoides farinae.", "population_specificity": "Children (n = 706) with a family history of allergic disease.", "effective_dosage": "800 mg/d DHA and 100 mg/d EPA.", "study_duration": "Prenatal supplementation (duration not specified in abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:51.399515+00:00"}
{"study_id": 187246, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine if a mixed flavonoid-fish oil supplement containing Docosahexaenoic Acid (DHA) could reduce inflammatory and oxidative stress markers and alter genomic profiles in overweight women.", "results_summary": "The study found that Q-Mix supplementation increased plasma DHA levels by 18% but did not significantly alter inflammatory markers like CRP or cytokines. However, it upregulated antiviral pathways and inhibited inflammatory pathways at the transcriptomic level.", "population_specificity": "Overweight and obese women aged 40-70 years (n = 48).", "effective_dosage": "180 mg DHA (as part of 400 mg n3-PUFAs) daily.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:51.845005+00:00"}
{"study_id": 187240, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to analyze the long-chain omega-3 fatty acid (DHA) status in German women during pregnancy and lactation and its association with postpartum depression.", "results_summary": "Pregnant women had significantly higher omega-3 index and DHA concentrations than lactating women. Supplementation with LC n-3 PUFA increased omega-3 index values, while smoking and later stages of pregnancy/lactation were negatively associated with omega-3 index.", "population_specificity": "German women aged 18-44, either pregnant (\u226527th week of gestation) or lactating.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:52.789268+00:00"}
{"study_id": 187245, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the long-term effects of DHA supplementation during pregnancy on children's neurodevelopment at 7 years of age.", "results_summary": "The study is ongoing, and results are not yet reported in the abstract. The primary outcome is IQ, with additional assessments of executive functioning, attention, memory, language, and educational skills.", "population_specificity": "Australian women with singleton pregnancies <21 weeks' gestation and their children (n=638 still enrolled at 7 years, including preterm and term births).", "effective_dosage": "800 mg DHA/day (3 capsules daily)", "study_duration": "From randomization (<21 weeks' gestation) until birth", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:53.612103+00:00"}
{"study_id": 187251, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of DHA supplementation on cytokine production by LPS-stimulated PBMCs after exercise and the influence of temperature.", "results_summary": "DHA supplementation attenuated exercise-induced increases in cytokine production by PBMCs but did not affect temperature-induced cytokine production. The study found significant increases in DHA content in erythrocytes in the supplemented group.", "population_specificity": "Fifteen male soccer players.", "effective_dosage": "1.16 g DHA/day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:59.186458+00:00"}
{"study_id": 187248, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how maternal characteristics influence the effects of prenatal docosahexaenoic acid (DHA) supplementation on maternal and offspring outcomes.", "results_summary": "Among non-smokers, DHA supplementation led to heavier babies and fewer low birth weight cases. Children of less-educated mothers had higher cognitive scores, while those of more-educated mothers had lower language scores with DHA supplementation.", "population_specificity": "Pregnant women and their offspring, stratified by maternal smoking status and education level.", "effective_dosage": "800mg/day", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:59.281649+00:00"}
{"study_id": 187250, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the mechanisms behind reduced maternal-fetal DHA transfer in diabetic mothers and assess the potential benefits of DHA supplementation for infant neurodevelopment.", "results_summary": "Maternal DHA supplementation is linked to better infant neurodevelopment, but maternal-fetal DHA transfer is reduced in diabetic mothers. The review highlights the need for further research on mechanisms, particularly the role of peroxisome proliferator-activated receptors in placental fatty acid binding.", "population_specificity": "Infants born to diabetic mothers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:59.458723+00:00"}
{"study_id": 187252, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to compare the safety, efficacy, and regulatory differences between prescription and dietary supplement forms of omega-3 fatty acids, particularly focusing on the effects of docosahexaenoic acid (DHA) on low-density lipoprotein cholesterol (LDL-C).", "results_summary": "The study found that products containing both EPA and DHA may raise LDL-C, while the EPA-only prescription product did not. Dietary supplements are not FDA-approved and may contain variable or harmful components, making them unsuitable substitutes for prescription products.", "population_specificity": "Patients with dyslipidemia (implied, not explicitly stated).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:00.724618+00:00"}
{"study_id": 187253, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to determine whether DHA-rich fish oil supplementation differentially affects platelet aggregation and cardiovascular risk markers compared to EPA-rich fish oil in healthy young men.", "results_summary": "The study found no significant effect of DHA-rich fish oil supplementation on platelet-monocyte aggregates or other vascular function markers after 6 weeks. DHA showed no significant differences compared to placebo in the measured outcomes.", "population_specificity": "48 healthy young men", "effective_dosage": "2.9 g DHA/day", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:01.000602+00:00"}
{"study_id": 187249, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the bioavailability of docosahexaenoic acid (DHA) from phospholipid-rich herring roe oil versus triglyceride-rich fish oil in adults with elevated fasting triacylglycerol levels.", "results_summary": "The study found that DHA from phospholipid-rich herring roe oil had significantly higher bioavailability compared to fish oil, with plasma phosphatidylcholine levels of DHA increasing substantially after supplementation. Both sources elevated fasting plasma DHA levels similarly after 2 weeks, but herring roe oil showed superior short-term absorption.", "population_specificity": "Thirty-two adults with fasting triacylglycerol concentrations between 100 and 399 mg/dL, stratified by sex and age.", "effective_dosage": "1810 mg/day DHA (herring roe oil) or 1843 mg/day DHA (fish oil), administered as 12 capsules/day.", "study_duration": "2 weeks per supplementation period, separated by a 4-week washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:01.214065+00:00"}
{"study_id": 187254, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether fish oil supplementation (containing EPA-DHA) modulates oxidative stress during gestation and postnatal life.", "results_summary": "Supplementation reduced plasma hydroperoxides in newborns and increased antioxidant enzymes (SOD, CAT) and nutrients (\u03b1-tocopherol, CoQ10) in mothers and newborns, indicating reduced oxidative stress.", "population_specificity": "110 pregnant women and their newborns.", "effective_dosage": "400 mg EPA-DHA/day via a fish oil-enriched dairy drink.", "study_duration": "From pregnancy through 4 months postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:01.775494+00:00"}
{"study_id": 187255, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of DHA in controlling obesity-related inflammation and reducing insulin resistance in breast cancer development, progression, and response to therapies.", "results_summary": "The study found that low basal DHA levels are linked to increased cancer risk and relapse, while DHA supplementation improves response to anticancer therapies and reduces side effects. However, controversy exists regarding DHA's anticancer effects, necessitating larger clinical trials.", "population_specificity": "Older women with obesity and breast cancer risk in western countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:07.780398+00:00"}
{"study_id": 187257, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers sought to determine whether maternal DHA supplementation during the second half of pregnancy reduces BMI and body fat percentage in children at 3 and 5 years of age.", "results_summary": "Maternal DHA supplementation did not significantly affect BMI z scores or body fat percentages in children at 3 or 5 years of age, nor did it interact with the PPAR\u03b3 genotype related to obesity predisposition.", "population_specificity": "Pregnant women with singleton pregnancies and their children followed up at 3 and 5 years of age.", "effective_dosage": "800 mg DHA/day", "study_duration": "Second half of pregnancy (approximately 20 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:08.343409+00:00"}
{"study_id": 187256, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of DHA supplementation on plasma eicosanoid levels and PBMC eicosanoid production in response to training and acute exercise.", "results_summary": "DHA supplementation increased COX-2 levels but decreased LPS-stimulated PBMC PGE1 and PGE2 production. It acted synergistically with exercise to increase plasma PGE2 with anti-inflammatory effects.", "population_specificity": "Fifteen male footballers.", "effective_dosage": "1.16 g DHA/day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:08.419072+00:00"}
{"study_id": 187258, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To observe the effects of fish oil (a source of Docosahexaenoic Acid) on pregnancy outcomes, including gestational age, preterm delivery, and newborn size.", "results_summary": "Fish oil supplementation was associated with increased gestational age, reduced risk of early preterm delivery (22%) and preterm delivery (10%), and improved newborn size (birth weight, length, and head circumference). No benefit was found for intrauterine growth restriction or stillbirth.", "population_specificity": "Pregnant women", "effective_dosage": "Not specified", "study_duration": "Duration of pregnancy (not explicitly stated)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:09.233856+00:00"}
{"study_id": 187260, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential health benefits and public health opportunities of bioactive constituents, specifically docosahexaenoic acid (DHA), and the need for establishing nutrient reference values (NRVs) for non-communicable disease endpoints.", "results_summary": "The abstract discusses the lack of established nutrient reference values for bioactive constituents like DHA, highlights the potential health benefits, and calls for further research and regulatory processes to evaluate their efficacy and safety. No specific study results on DHA's effects are provided.", "population_specificity": "Not specified", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:10.022257+00:00"}
{"study_id": 187259, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of APOE genotype on gene expression changes in response to fish-oil supplementation containing docosahexaenoic acid.", "results_summary": "Fish-oil supplementation differentially regulated gene expression in APOE4 carriers, reducing IFN-related gene expression and showing potential benefits for cholesterol biosynthesis pathways. The study suggests docosahexaenoic acid may particularly benefit APOE4 carriers by modulating gene expression linked to cardiovascular risk.", "population_specificity": "APOE4 carriers (N = 8) and noncarriers (N = 15)", "effective_dosage": "1800 mg of combined eicosapentaenoic acid and docosahexaenoic acid per day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:10.384466+00:00"}
{"study_id": 187247, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the levels of docosahexaenoic acid (DHA) in human breast milk between preterm and term infants and assess whether supplementation might be needed for preterm infants.", "results_summary": "The study found that DHA levels in preterm infants' breast milk were comparable to those in term infants' breast milk (0.43% vs. 0.35% of total lipids). However, overall concentrations of DHA and other nutrients decreased after birth, suggesting potential inadequacy for fetal accretion rates in preterm infants.", "population_specificity": "Mothers of preterm infants (postmenstrual age 30 weeks, range 25.4-32.0) and mothers of term infants.", "effective_dosage": "Not specified (measured as % of total lipids in breast milk).", "study_duration": "Postnatal day 6-85 for preterm infants, day 6-118 for term infants.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:11.839829+00:00"}
{"study_id": 187261, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of omega-3 PUFA supplementation, including docosahexaenoic acid (DHA), on depressive symptoms in adults with major depressive disorder (MDD).", "results_summary": "The meta-analysis found a beneficial overall effect of omega-3 PUFA supplementation on depressive symptoms in MDD patients, with higher doses of EPA and concurrent antidepressant use associated with better outcomes. Significant heterogeneity was observed, partly explained by EPA dose, antidepressant use, and publication year.", "population_specificity": "Adult patients with major depressive disorder (MDD), excluding perinatal/perimenopausal or comorbid MDD cases.", "effective_dosage": "Not specified for DHA (focus was on EPA dose and EPA/DHA ratio).", "study_duration": "Not specified (duration varied across included studies).", "interactions": "Potential interaction between EPA and antidepressants noted, suggesting improved outcomes when combined.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:12.553502+00:00"}
{"study_id": 187262, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether n\u20133 supplementation (DHA plus EPA) during pregnancy affects lipid metabolism in the placentas of overweight and obese women at term.", "results_summary": "Supplementation with n\u20133 FAs significantly reduced placental lipid content, decreased expression of genes involved in lipid esterification, and increased birth weight and length in offspring, without affecting FA oxidation or uptake genes.", "population_specificity": "Healthy overweight and obese pregnant women.", "effective_dosage": "2 g/d (DHA plus EPA), twice a day.", "study_duration": "From early pregnancy to term.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:15.990327+00:00"}
{"study_id": 187263, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess whether prenatal DHA supplementation's effect on birth weight varied across specific FADS gene SNPs in Mexican women.", "results_summary": "The study found no overall intention-to-treat differences in birth weights but identified significant heterogeneity in response based on SNP rs174602, with TT and TC carriers showing higher birth weights in the DHA group compared to placebo. No significant effects were observed for the other three SNPs analyzed.", "population_specificity": "Mexican women and their offspring.", "effective_dosage": "400 mg DHA daily.", "study_duration": "From weeks 18-22 of gestation through delivery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:17.391927+00:00"}
{"study_id": 187267, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of DHA alone or as part of a multinutrient supplement on cerebral hemodynamics and cognitive function in older adults with subjective memory deficits.", "results_summary": "The study found no significant effects of DHA or the multinutrient supplement on cerebral hemodynamics or cognitive performance tasks, though limitations were noted.", "population_specificity": "Healthy older adults aged 50-70 years with subjective memory deficits.", "effective_dosage": "Not specified", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:17.879584+00:00"}
{"study_id": 187266, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "To compare the clinical use, safety, and efficacy of prescription and dietary supplement omega-3 fatty acid products, focusing on EPA and DHA.", "results_summary": "Prescription OM3-FA products containing DHA and EPA demonstrated significant triglyceride reduction, but DHA was associated with increased LDL cholesterol, which may complicate dyslipidemia management. Dietary supplements showed variability in EPA and DHA content and potential contamination with harmful components.", "population_specificity": "Patients with hypertriglyceridemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:18.008550+00:00"}
{"study_id": 187265, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether long-chain polyunsaturated omega-3 fatty acids (LC-n3-FA), including Docosahexaenoic Acid, improve memory functions in cognitively healthy older adults.", "results_summary": "The study found that LC-n3-FA supplementation significantly improved recall of object locations compared to placebo, though it did not significantly affect performance in the Rey Auditory Verbal Learning Test. The omega-3 index also increased significantly in the supplemented group.", "population_specificity": "Cognitively healthy individuals aged 50-75 years (44 participants, 20 female).", "effective_dosage": "2,200 mg/day", "study_duration": "26 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:18.012147+00:00"}
{"study_id": 187264, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether oral docosahexaenoic acid (DHA) supplementation affects drusen progression in patients with unilateral neovascular age-related macular degeneration (AMD).", "results_summary": "The study found no significant association between DHA supplementation and drusen remodeling outcomes. Drusen reduction was correlated with increased age and female gender, and showed a tendency to be influenced by CFH genotype, but DHA supplementation did not appear to have an effect.", "population_specificity": "300 subjects with age-related maculopathy and neovascular AMD in one eye (study-eye).", "effective_dosage": "840 mg/day", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:18.864410+00:00"}
{"study_id": 187268, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the role of docosahexaenoic acid (DHA) and other omega-3 fatty acids in psychiatric disorders and assess the potential benefits of fish oil supplementation in correcting deficiencies.", "results_summary": "The study found that 75% of psychiatric patients had low EPA + DHA levels, and fish oil supplementation improved symptoms in some cases without notable side effects. The results support screening and treating omega-3 deficiencies in psychiatric care.", "population_specificity": "Patients with treatment-refractory mood or anxiety disorders in a residential inpatient clinic.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:20.258436+00:00"}
{"study_id": 187269, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the feasibility, tolerability, and efficacy of daily enteral DHA supplementation (50 mg/day) in preterm infants to alleviate DHA deficiency.", "results_summary": "Preterm infants receiving DHA supplementation showed a progressive increase in circulating DHA levels, while placebo-supplemented infants showed no increase. Despite supplementation, preterm infants still had lower DHA levels than term peers at discharge, but no differences in adverse events were observed.", "population_specificity": "Preterm infants (24-34 weeks gestational age) and term peers for comparison.", "effective_dosage": "50 mg/day", "study_duration": "From the first week of life until near discharge (specific duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:21.931679+00:00"}
{"study_id": 187270, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of DHA-rich fish oil supplementation on body composition, plasma adiponectin levels, and PPAR\u03b3 gene expression in T2DM patients, and whether these effects were influenced by PPAR\u03b3 Pro12Ala polymorphism.", "results_summary": "DHA-rich fish oil supplementation significantly reduced waist circumference, body fat mass, body fat percent, viscera fat rating, and trunk fat mass in T2DM patients, but did not affect glycemic control, weight, BMI, fat-free mass, adiponectin levels, or PPAR\u03b3 gene expression. No gene-diet interaction was observed.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM)", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:25.261304+00:00"}
{"study_id": 187272, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine if dietary DHA and EPA supplementation differentially affect circulating CD36 + MP levels in healthy men and women.", "results_summary": "The study found no significant changes in CD36 + MP levels after DHA or EPA supplementation in either gender, suggesting that the cardioprotective effects of these fatty acids do not act through a CD36 + MP mechanism.", "population_specificity": "Healthy men (43) and women (51) aged 39.6 \u00b1 1.7 years.", "effective_dosage": "DHA-rich (200 mg EPA; 1000 mg DHA daily), EPA-rich (1000 mg EPA; 200 mg DHA daily), or placebo.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:27.248253+00:00"}
{"study_id": 187274, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 90, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) supplementation, alone or with vitamin D, prevents cancer and cardiovascular disease in adults without prior history of these conditions.", "results_summary": "The abstract does not report specific results for DHA, as the study is ongoing and outcomes are not yet available.", "population_specificity": "25,874 U.S. adults (men aged \u226550, women aged \u226555) without cancer or CVD at baseline, including an oversample of African Americans (n=5,107).", "effective_dosage": "1 g/day (combined EPA and DHA).", "study_duration": "Mean of 5 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:27.536379+00:00"}
{"study_id": 187273, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of marine omega-3 fatty acids (including docosahexaenoic acid) on pneumonia risk, respiratory exacerbations, asthma control, and lung function in adults.", "results_summary": "The study is ongoing, but it is designed to assess the potential benefits of omega-3 supplementation on respiratory health, with outcomes measured through yearly follow-up questionnaires and lung function tests.", "population_specificity": "Adults aged \u226550 (men) and \u226555 (women), including 5107 African Americans and a subset of 1973 participants from 11 urban U.S. centers.", "effective_dosage": "1g/day (eicosapentaenoic acid + docosahexaenoic acid)", "study_duration": "5 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:27.803908+00:00"}
{"study_id": 187271, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on cortical blood oxygen level-dependent (BOLD) activity during a working memory task in older adults with subjective memory impairment.", "results_summary": "Fish oil supplementation increased erythrocyte omega-3 content, improved working memory performance, and enhanced BOLD signal in the posterior cingulate cortex during memory tasks. The changes in omega-3 levels were associated with better performance and increased neural activity in memory-related brain regions.", "population_specificity": "Healthy older adults (62-80 years) with subjective memory impairment but not meeting criteria for mild cognitive impairment or dementia.", "effective_dosage": "2.4 g/d (combined EPA+DHA)", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:27.861826+00:00"}
{"study_id": 187275, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the optimal dose of DHA for attenuating serum NFL (a biomarker of axonal injury) in American football athletes exposed to subconcussive impacts.", "results_summary": "DHA supplementation increased plasma DHA in a dose-dependent manner and likely attenuated serum NFL increases, suggesting a neuroprotective effect. Starters showed greater NFL increases than nonstarters, but DHA supplementation reduced NFL levels across all doses.", "population_specificity": "National Collegiate Athletic Association Division I American football athletes (n=81).", "effective_dosage": "2, 4, or 6 g\u00b7d of DHA.", "study_duration": "189 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:28.750639+00:00"}
{"study_id": 187276, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate how different dietary fats (SFA vs. n-6PUFA) influence the incorporation of n-3PUFA (including docosahexaenoic acid) into plasma and erythrocytes, as well as their effects on blood lipid profiles.", "results_summary": "The study found that n-3PUFA supplementation with SFA led to greater increases in eicosapentaenoic acid and docosahexaenoic acid in plasma and erythrocytes compared to n-6PUFA, though docosahexaenoic acid changes were not statistically significant. SFA also increased total cholesterol and LDL-C more than n-6PUFA.", "population_specificity": "Not specified in the abstract (likely human subjects given the trial design).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:30.998307+00:00"}
{"study_id": 187277, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 20, "quality_score": 80, "study_goal": "The researchers aimed to determine whether high-dose omega-3 fish oil (containing docosahexaenoic acid) could impact bone mineral density in adults with knee osteoarthritis.", "results_summary": "The study found no significant differences in bone mineral density between high-dose and low-dose omega-3 fish oil groups after two years. Mild adverse events like headache and gastrointestinal intolerance were common but not more frequent in either group, and no serious adverse events were reported.", "population_specificity": "Australian adults aged \u226540 with knee osteoarthritis (mean age 61.0 \u00b1 10.0 years; 49% female).", "effective_dosage": "High dose (4.5 g EPA and DHA daily) vs. low dose (0.45 g/day).", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:31.817671+00:00"}
{"study_id": 187278, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of DHA-rich fish oil supplementation on PPAR\u03b3-responsive genes related to lipid metabolism in type 2 diabetes patients.", "results_summary": "DHA-rich fish oil supplementation significantly reduced triglyceride levels, particularly in hypertriglyceridemic subjects, and upregulated CD36 expression in this group, but did not affect other lipid parameters or the expression of other studied genes.", "population_specificity": "Patients with type 2 diabetes, including hypertriglyceridemic and normotriglyceridemic subjects.", "effective_dosage": "2400 mg/d fish oil (DHA: 1450 mg, EPA: 400 mg)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:34.176463+00:00"}
{"study_id": 187279, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-inflammatory and insulin-sensitizing effects of DHA in children with NAFLD and its mechanism via GPR120 activation.", "results_summary": "DHA demonstrated anti-inflammatory and insulin-sensitizing effects in children with NAFLD by altering cell membrane phospholipids, disrupting lipid rafts, and inhibiting NF-\u03baB activity. These effects were linked to GPR120 activation in macrophages and Kupffer cells, suggesting DHA may slow NAFLD progression.", "population_specificity": "Children with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:36.410113+00:00"}
{"study_id": 187282, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of omega-3 fatty acids, particularly docosahexaenoic acid (DHA), in preventing age-related macular degeneration (AMD) and to reconcile conflicting results from prior studies.", "results_summary": "The study suggests that omega-3 fatty acids may still have prophylactic potential for AMD, despite the negative results of AREDS2, citing methodological differences and supporting evidence from epidemiological and clinical studies. Patients with high red blood cell EPA/DHA levels showed significant protection against AMD compared to those with low levels.", "population_specificity": "Patients at risk for or with age-related macular degeneration (AMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:37.011929+00:00"}
{"study_id": 187281, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of fish oil supplementation (containing DHA and EPA) on cardiometabolic health and inflammatory status between young and older men.", "results_summary": "Both young and older men experienced a \u223c30% reduction in blood triglycerides, but young men showed a \u223ctwofold increase in DHA levels in serum and RBCs, while older men had negligible increases. Fish oil also improved oxylipin profiles in both groups, with similar changes observed in specific oxylipins.", "population_specificity": "Healthy young and older men.", "effective_dosage": "2.0 g/d EPA and 1.0 g/d DHA (five fish oil capsules daily).", "study_duration": "Three months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:37.357892+00:00"}
{"study_id": 187280, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether a 26-week intervention with n-3 PUFA (2.2 g/day) could reduce symptom severity and improve functioning in first-episode schizophrenia patients compared to placebo.", "results_summary": "The study found that n-3 PUFA significantly improved total symptom severity (PANSS), general psychopathology, depressive symptoms, functioning, and clinical global impression compared to placebo, with moderate effect sizes. A 50% improvement in symptom severity was achieved more frequently in the n-3 PUFA group (69.4% vs. 40.0%).", "population_specificity": "First-episode schizophrenia patients aged 16-35.", "effective_dosage": "2.2 g/day of n-3 PUFA.", "study_duration": "26 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:37.631212+00:00"}
{"study_id": 187283, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine if high-DHA supplementation in very preterm infants improves visual-processing outcomes at age 7 compared to standard-DHA supplementation.", "results_summary": "The study found no significant differences in visual-processing measures between the high-DHA and standard-DHA groups, with most outcomes slightly favoring the control group. The study had sufficient power to detect moderate effects but found none.", "population_specificity": "Very preterm infants (stratified by sex and birth weight <1250 or \u22651250 g).", "effective_dosage": "High-DHA group: 1% of total fatty acids; control group: 0.2-0.3% of total fatty acids.", "study_duration": "First months of life (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:38.906485+00:00"}
{"study_id": 187284, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether dietary supplementation with omega-3 PUFA, including docosahexaenoic acid, modulates reproductive hormones in reproductive-age women.", "results_summary": "Omega-3 PUFA supplementation reduced FSH levels and response to GnRH in normal-weight women but not in obese women. It also decreased inflammatory markers (IL-1\u03b2 and TNF-\u03b1) in obese women, though without associated hormonal changes.", "population_specificity": "Fifteen obese and 12 normal-weight eumenorrheic women, ages 28-34 years.", "effective_dosage": "4 g daily (combined eicosapentaenoic acid and docosahexaenoic acid).", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:40.535843+00:00"}
